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Abstract
Obese women experience frequent infertility; obesity-conditioned reproductive tracts expose
embryos to stressors including free fatty acids (FFA). Palmitic acid (PA) exposure significantly
impairs mouse preimplantation development and increases endoplasmic reticulum stress; oleic
acid (OA) rescues these effects. To further understand FFA in preimplantation development, this
thesis investigates the NRF2/KEAP1 pathway, which coordinates antioxidant stress response
pathways. We hypothesize that PA induces the NRF2/KEAP1 pathway, while OA alleviates it.
Female mice were super-ovulated, mated, and embryos were placed in culture treatments: bovine
serum albumin (control), 100 µM PA, 100 µM OA, or 100 µM PA+OA. Protein localization and
mRNA abundances were assessed via immunofluorescence and RT-qPCR, respectively. NRF2
displayed nuclear localization throughout preimplantation development. PA significantly
decreased NRF2-positive nuclei, while OA and PA+OA did not. FFAs showed no significant
effects on relative expression of Nrf2/Keap1. Current results suggest that PA suppresses
NRF2/KEAP1 pathway activation, which warrants further investigation as a mechanism for PAinduced developmental impairments.
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Summary for Lay Audience
Infertility impacts nearly 1 in 6 couples globally. The high prevalence of infertility has driven
increased demand for assisted reproductive technologies, which are techniques—such as in vitro
fertilization or embryo transfer—that assist couples to successfully conceive and carry healthy
pregnancies to term. Many techniques focus on preimplantation embryo development, which is
the period starting at fertilization and ending when the embryo implants in the uterus. Importantly,
patients experience varying ART success rates due to factors like age and health. Obese women
experience higher incidences of infertility than women with healthy BMIs, and obesity has been
increasing for decades, prompting studies into why obese patients face these challenges. Obesity
changes the reproductive tract environment, exposing embryos to external stressors during
development, including macromolecules called fatty acids. Previous research indicates that
exposing preimplantation mouse embryos to palmitic acid, an abundant fatty acid in the body,
impairs embryo development and induces stress responses. In contrast, exposing preimplantation
embryos to oleic acid, another abundant free fatty acid, reverses the negative effects of palmitic
acid. Given that palmitic acid impacts stress responses, this thesis investigated the NRF2/KEAP1
signalling pathway, which coordinates cellular defences against stress. KEAP1 normally binds to
NRF2 to promote its degradation. Under cellular stress conditions, NRF2 enters the nucleus to
promote antioxidant gene expression, which helps the cell deal with stressors. We hypothesized
that treating mouse preimplantation embryos with palmitic acid would induce the NRF2/KEAP1
pathway, while treating embryos with oleic acid would alleviate it. Mouse embryos were cultured
in vitro in the following treatments: fatty acid carrier, palmitic acid, oleic acid, palmitic & oleic
acid, or plain culture media. Embryos were imaged to visualize localization of NRF2/KEAP1
proteins in response to fatty acids treatments. Palmitic acid significantly decreased the percentage
of embryonic cells with nuclear NRF2 localization, which indicated less activation, since NRF2
functions inside the nucleus. Oleic acid and the combination treatment did not produce this effect.
My findings suggest that palmitic acid suppresses NRF2/KEAP1 activity, which could prevent
cells from properly responding to stressful conditions such as obesity, presenting a mechanism for
palmitic acid impairing preimplantation embryo development.
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Chapter 1: Introduction
1.1 Assisted Reproductive Technologies
Infertility impacts nearly 1 in 6 couples globally (Farquhar et al., 2015) as well as almost 1 in 10
women of reproductive age (Szamatowicz, 2016). Infertility is a unique health problem in that it
commonly affects two people, and has therefore been designated as a social disease by the World
Health Organization (Szamatowicz, 2016). The prevalence of infertility is driving the increased
demand for assisted reproductive technologies (ARTs) to achieve successful and healthy
pregnancies (Farquhar et al., 2015; Szamatowicz, 2016). Common fertility treatments include:
intrauterine insemination, controlled ovarian stimulation, in vitro oocyte maturation, in vitro
fertilization, intracytoplasmic sperm injection, embryo culture, and elective single embryo transfer
(eSET) (Esteves et al., 2019; Kushnir et al., 2017; Okun et al., 2014; Soysal & Ozmen, 2018).
ARTs target a range of physiological processes including oocyte maturation and fertilization,
preimplantation embryo development, and embryo transfer. The primary goal of ARTs is to
therapeutically target a diagnosed cause of infertility; however, underlying comorbidities vary
among individuals and include multiple intersecting factors such as age, health and medical history
(Szamatowicz, 2016).
Despite admirable technological advances in assisted reproduction and improvements in human
fertility medicine throughout the past few decades, fertility treatments remain successful only
about 50–65% of the time (Baird et al., 2013). Even so, the 50–65% success rate does not take into
account successful pregnancies and baby take-home rates, which unfortunately only occurs 25–
30% of the time (Kupka et al., 2014; Sunderam et al., 2017; Truong et al., 2016). Thus, most
patients seeking fertility medicine for family planning do not achieve their goals; research is
required to improve the success of fertility treatments and to ensure that success represents the
occurrence of healthy babies and children for all aspiring parents. The research in this thesis will
explore the mechanisms underlying the existence of infertility in obese patients, with the goal of
contributing to the physiological knowledge base that will ultimately result in clinical benefits for
this patient population.
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1.2 Obesity and Fertility
Obese women struggle with infertility at a higher incidence than patients with a healthy body mass
index (BMI) (Talmor & Dunphy, 2015). While there is currently significant debate regarding the
accuracy and utility of the BMI measure for defining excess weight and obesity at an individual
level, it is still commonly used to measure obesity at a population level (O’Rourke, 2018). Obesity,
defined as having a BMI of 30 kg/m2 or higher, is the result of complex relationships between
genetic, social and behavioural factors (Apovian, 2016). Measuring abdominal obesity in terms of
visceral adipose tissue is also commonly used to assess the metabolic health of obese individuals
(Fang et al., 2018). In recent decades, obesity has become a serious epidemic, primarily in
developed countries but also increasingly on a global level; in 2018, Statistics Canada reported
that 56.7% of Canadian women and 69.4% of men were overweight or obese according to BMI
distribution (Statistics Canada, 2019). Obesity is associated with health risks and comorbidities
including metabolic disorders, cardiovascular disease, type 2 diabetes and many types of cancer
(Apovian, 2016; Guh et al., 2009).
Importantly, obesity is also associated with impaired reproductive health (Broughton & Moley,
2017; McKeegan & Sturmey, 2012; Shah et al., 2011). The effects of maternal obesity on
reproductive health include irregular menstruation, decreased gonadotropin production, severe
phenotypes of polycystic ovarian syndrome, ovulatory dysfunction, and increased time to
pregnancy, among others (Broughton & Moley, 2017). Additionally, obese patients exhibit
impaired oocyte developmental competence and early embryo development (Yousif et al., 2020).
Furthermore, even when seeking the help of ARTs, obese women require an increased number of
fertility treatment cycles to successfully conceive a pregnancy compared with healthy BMI
patients (Shah et al., 2011). Most importantly, the successful full-term pregnancy outcomes for
obese patients are much lower than those observed for healthy BMI patients (Sermondade et al.,
2019).
Obesity certainly alters the in vivo environment in the reproductive tract that supports
preimplantation embryo development, with consequences for the developmental competence of
exposed preimplantation embryos (McKeegan & Sturmey, 2012). Overweight and obese women
(BMI >25 kg/m2) achieve lower rates of pregnancy after in vitro fertilization, require increased
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gonadotrophin doses during ovarian stimulation protocols, and experience higher rates of
miscarriage (Maheshwari et al., 2007). Further research is required to determine the mechanisms
underlying these in vivo and in vitro effects of obesity on female reproductive health and infertility.

1.3 Preimplantation Embryo Development
Preimplantation embryo development is generally defined as the free-living period of development
between fertilization of the mature oocyte and uterine implantation of the blastocyst-stage embryo
(Wamaitha & Niakan, 2018). Early development is complex, requiring precise organization and
coordination of events to produce a competent embryo that can successfully grow into an
organism. Among other mammals, mouse and human embryos exhibit a number of temporal and
morphological similarities during their early developmental stages (Figure 1; Chazaud &
Yamanaka, 2016; Quinn & Horstman, 1998; Taft, 2008; Wamaitha & Niakan, 2018).
Preimplantation embryo development is a common process targeted during application of ARTs—
for example, eSET relies on high quality blastocyst embryos—so studying this developmental
period using in vitro methods is an important and relevant pursuit.
Human preimplantation development begins with fertilization—fusion of sperm and oocyte to
produce the single-celled zygote—in the fallopian tube (Niakan et al., 2012; Wamaitha & Niakan,
2018). Mouse oocyte fertilization occurs in the analogous structure called an oviduct (Fujimori,
2010). Sperm binding to the oocyte membrane—oolemma—and its uptake by the oocyte during
fertilization prompts a sperm-induced protein kinase C-𝜁 (PKC𝜁) signaling cascade resulting in
the release of calcium ions from stores inside the oocyte (Wakai et al., 2011). Rising intracellular
calcium levels ultimately trigger completion of oocyte meiosis which fosters development of both
female and male pronuclei, resulting in syngamy and production of a unique diploid 1-cell zygote
(Wamaitha & Niakan, 2018). The zygote transitions from meiosis to mitosis, enabling the early
cleavage divisions of embryogenesis (Wamaitha & Niakan, 2018).
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/ICM

Figure 1. Representative timeline of (A) mouse and (B) human preimplantation embryo
development.
The major stages of preimplantation embryo development are similar and comparable between
mice and humans. Embryos of the two species progress on different timelines, indicated by (A)
mouse and (B) human embryonic age in days. Figure adapted from (Yousif, 2019). Copyright
permission found in Appendix B.
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From the zygote stage, subsequent cleavage cell divisions take the embryo through the 2-cell, 4cell and 8-cell stages of development (Chazaud & Yamanaka, 2016; Niakan et al., 2012). In
mammalian embryos, the cleavage stages span approximately 18–40 hours post-fertilization
(Jukam et al., 2017). Cytoplasmic volume from the single-celled zygote remains constant during
embryo cleavage, as the existing cytoplasm is segmented into increasingly smaller blastomeres
with each cell division (Aiken et al., 2004; Maître, 2017). The zona pellucida, an oocyte-produced
glycoprotein membrane originating during oogenesis, surrounds the embryo and physically
contains early embryo development (Maître, 2017). The zona pellucida ensures normal transport
through the oviduct or fallopian tube to the uterus, and prevents ectopic pregnancy from occurring
(Zhao & Dean, 2002). Cell divisions occur asynchronously during mammalian preimplantation
development; each cell division does not necessarily represent a perfect doubling of total
embryonic cell number (Fujimori, 2010).
In developing preimplantation embryos, the initial cleavage divisions encompass a pivotal event
called the maternal-to-zygotic transition (MZT) (Lee et al., 2014). Following oogenesis and
attainment of optimal oocyte growth, the oocyte and zygote enter a phase of transcriptional
quiescence (Lee et al., 2014). In the mouse, transcription is first detected in the mouse male
pronucleus, but MZT is not fully initiated until the 2-cell stage, when the new embryonic genome
becomes transcriptionally active (Sha et al., 2020). Embryonic transcriptional activity increases
throughout preimplantation development as the embryonic genome increasingly assumes control
over the developmental program, reaching its highest levels at the blastocyst stage (Hamatani et
al., 2004). Interestingly, preimplantation development still retains some dependence on key events
driven by oocyte/maternal mRNA and proteins, likely until implantation and beyond, which
highlights the role of oocyte maturation in contributing to full embryonic developmental capacity
for initiating pregnancy (Jukam et al., 2017; Lee et al., 2014; Wamaitha & Niakan, 2018). Thus,
MZT encompasses at least two major transitions: turnover and loss of oogenetic/maternal
instructions for early embryogenesis after they have completed their contribution (Lee et al., 2014),
and activation of the zygotic genome that will oversee the developmental program for embryonic
cell fate, differentiation, and preimplantation development (Jukam et al., 2017; Lee et al., 2014).
In addition to the first zygotic wave of transcriptional activity at the 2-cell stage in mice (Knowland
& Graham, 1972; Lee et al., 2014), a second wave, known as the mid-preimplantation wave, occurs
between the 4- and 8-cell stages, with a third pre-blastocyst wave arising just prior to cavitation
5

(Jukam et al., 2017). Genome activation continues until transcriptional activity of the embryonic
genome is functioning at full capacity and prepared to control subsequent development (Jukam et
al., 2017).
Thus, genome activation is well underway by the 8-cell stage, providing pivotal changes that
prepare embryonic cells to undergo compaction, which is the first morphogenetic event of
preimplantation development that initiates cell differentiation, polarity, and formation of the
morula (Jukam et al., 2017; Niakan et al., 2012). During compaction, each blastomere from the 8cell stage begins to show increased cell-cell adhesion contacts and apical-basolateral polarity,
which arise due to the development of E-cadherin-based adherens junctions between all
blastomeres (Frankenberg et al., 2016; Fujimori, 2010). Compaction of blastomeres is not perfectly
synchronized, with some cells showing polarity and adhesion properties earlier than others
(Chazaud & Yamanaka, 2016). Recent research suggests that cytoskeletal forces, namely filopodia
and actin-myosin contractility, are important drivers of compaction (Maître, 2017). E-cadherinbased adhesion molecules provide structural stability and signaling bases within blastomeres to
support the cytoskeletal forces acting on compaction (Maître, 2017). Morula compaction in the
mouse embryo occurs two cell divisions prior to blastocyst formation (Frankenberg et al., 2016).
Morula formation also represents a major shift toward blastomere lineage specification as embryo
development continues (Chazaud & Yamanaka, 2016). The two major lineages established during
compaction are the inner cell mass (ICM; epiblast), which will eventually comprise embryonic
tissues, and the trophectoderm (TE) lineage, which will develop into extraembryonic tissues
including the placenta (Jukam et al., 2017). Apical-basolateral cell polarity established during the
8-cell stage is essential for TE cell lineage differentiation. The ICM lineage does not polarize,
which is critical for maintaining its pluripotency and ability to contribute to embryonic cell
lineages following implantation (Fujimori, 2010). The outer cells of the compacted morula develop
polarized cell domains that express key protein constituents of the Hippo signaling pathway;
namely, the intracellular localization of Yes-associated protein (Yap) (Maître, 2017; Yamamura
et al., 2020). Hippo signalling is turned off in outer cells of the morula; Yap is dephosphorylated
and is thus able to translocate to the nucleus where it acts as a coactivator of transcriptional
enhancer associate domain 4 (Tead4) (Nishioka et al., 2009; Yamamura et al., 2020). Active Tead4
induces caudal type homeobox 2 (Cdx2) expression, an important regulator of TE lineage
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determination, among other TE-associated genes (Maître, 2017; Nishioka et al., 2009; Yamamura
et al., 2020). In inner embryonic cells, Hippo signalling is turned on; thus, phosphorylated Yap
remains in the cytoplasm, preventing it from interacting with Tead4 or inducing Cdx2 expression
(Yamamura et al., 2020). Instead, sex determining region Y-box 2 (Sox2) expression is induced,
which influences ICM lineage differentiation into a cell lineage called the primitive endoderm
(Yamamura et al., 2020).
The final phase of preimplantation development, known as blastocyst formation or cavitation, is
characterized by establishment of a fluid-filled cavity (Maître, 2017). TE lineage cells comprising
the outermost layer of the embryo contain aquaporins and Na+/K+ transporters that facilitate the
movement of water and ions into the growing cavity (Frankenberg et al., 2016; Giannatselis et al.,
2011; Wamaitha & Niakan, 2018). The ICM is positioned at one interior pole of the developing
blastocyst cavity (Frankenberg et al., 2016). The TE epithelium bordering the cavity later develops
into extraembryonic tissues, namely the placenta, following uterine implantation to initiate
pregnancy and fetal development (Frankenberg et al., 2016). Successful uterine implantation
requires a combination of receptive uterine lining and competent early embryo development to the
blastocyst stage. Implantation also involves hatching of the blastocyst from the zona pellucida to
gain access to the uterine lining (Jukam et al., 2017). The culmination of these myriad complex
developmental events during preimplantation embryo development results in initiation of
pregnancy.

1.4 Preimplantation Embryo Adaptive Stress Responses
The maternal reproductive tract provides the in vivo environment for preimplantation embryo
development. From oocyte maturation in the ovarian follicle, to ovulation, fertilization, and
implantation, the embryo must traverse the oviduct/fallopian tubes and uterus while
preimplantation development occurs. Consequently, preimplantation embryos are exposed to
existing maternal stressors within the reproductive tract (Snider & Wood, 2019). During the
application of ARTs, preimplantation embryos are exposed to the in vitro culture environment,
which also contains key stressors such as atmosphere-induced reactive oxygen species (ROS),
culture medium osmolarity and culture medium substrate concentrations (Szamatowicz, 2016).
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Embryo culture is inherently stressful to the embryo, simply because no medium available today
will perfectly replicate the ideal in vivo environment (Wale & Gardner, 2016).
Early embryos are equipped with significant capacity to respond adaptively to their environment.
Endoplasmic reticulum (ER) stress response pathways, dominated by the unfolded protein
response (UPR), are adaptive mechanisms activated by early embryonic cells in response to
environmental stressors (Lin et al., 2019). The UPR acts through three main pathways, modulated
by transmembrane protein sensors activating transcription factor 6 (ATF6), protein kinase R-like
ER kinase (PERK), and inositol-requiring enzyme 1 (IRE1) to promote cell survival under stressful
conditions (Lin et al., 2019). Preimplantation embryos are sensitive to many stimuli in their in vivo
or in vitro environments including temperature, chemical exposure, and oxidative stress (Lin et al.,
2019). Any of these stimuli can produce ER stress, causing blastomeres to engage the UPR and
restore homeostasis; however, prolonged stressful conditions burdening the ER can trigger
apoptosis (Lin et al., 2019). In the context of embryo development, environmental stressors that
overload ER stress mechanisms can result in developmental arrest of the early embryo.

1.5 Lipotoxicity & Cellular Stress
Maternal obesity is closely linked with the metabolic state of lipotoxicity, defined as the
accumulation of lipids in non-adipose tissue (Mota et al., 2016). Lipotoxicity occurs as a result of
dysregulated metabolism in adipose tissue (Boden, 2011), which primarily stores caloric excess in
the form of lipid droplets (O’Rourke, 2018). Although the main role of adipose tissue is storage,
it is not physiologically passive; in fact, adipose is a metabolically active tissue with complex and
sophisticated mechanisms regulating its function (Boden, 2011; O’Rourke, 2018). Adipose tissue
regulates lipid trafficking via membrane transporters, but also secretes a number of metabolically
relevant compounds including proinflammatory cytokines, angiotensin II and the satiety hormone
leptin, among others (Boden, 2011; Kershaw & Flier, 2004).
Healthy, functional adipocytes are important for proper metabolic function; however, in the
presence of excess nutrients, which is the case in obese individuals, adipocytes must try to adapt.
In such cases, adipocytes respond to nutrient excess with cellular hypertrophy (O’Rourke, 2018).
Hypertrophy begins as an adaptive mechanism, but adipocytes surpassing a threshold diameter of
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approximately 100 µm trigger cellular stress responses (O’Rourke, 2018). Enlarged adipocytes
reaching their physical limit will result in overflow of lipids, including free fatty acids (FFA), into
the systemic circulation (Boden, 2011; O’Rourke, 2018). The body responds by shifting metabolic
pathways away from glucose in favour of lipids, contributing to increased insulin resistance in
peripheral tissues, and increased FFA in plasma circulation (O’Rourke, 2018).
Increased FFA levels in circulation result in the metabolic state called lipotoxicity. Elevated FFAs
can induce cellular stress pathways and increase mitochondrial ROS production (Boden, 2011;
Itani et al., 2005). Cellular lipid metabolism relies on the mitochondria; impairments in
mitochondrial respiration lead to abnormally high ROS accumulation and downstream oxidative
stress conditions (Gao et al., 2018). Sustained elevated ROS levels constitute chronic stress, and
can induce ER stress pathway activation, apoptosis and developmental arrest of early embryos
(Favetta et al., 2007).

1.6 Palmitic Acid & Oleic Acid
It is established that increased FFA levels can induce cellular stress (Boden, 2011; Gao et al., 2018;
Itani et al., 2005). Two non-esterified fatty acids, palmitic acid (PA) and oleic acid (OA), are of
particular interest because they are the most abundant FFAs in plasma circulation and in the
reproductive tract (Abdelmagid et al., 2015; Jungheim et al., 2011). Profiling of follicular fluid has
determined that PA and OA occupy approximately 27% and 31% of fatty acid content, respectively
(Jungheim et al., 2011). PA is a 16-carbon saturated fatty acid (16:0) (Figure 2), and OA is an 18carbon monounsaturated fatty acid (18:1) (Figure 3; Palomer et al., 2018). PA and OA are present
at serum concentrations of approximately 100 µM in healthy BMI individuals, but serum levels
can be elevated to anywhere between 200–400 µM in obese individuals (X. Chen et al., 2010;
Colvin et al., 2017; Villa et al., 2009).
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Figure 2. Molecular structure of palmitic acid (PA).
PA is a saturated fatty acid (C16:0) and one of the most abundant non-esterified fatty acids in both
plasma circulation and follicular fluid.

Figure 3. Molecular structure of oleic acid (OA).
OA is a monounsaturated fatty acid (C18:1) and one of the most abundant non-esterified fatty acids
in plasma circulation and follicular fluid.
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Although both FFAs are commonly found in the body, as well as being elevated in obesity, they
are associated with different outcomes. For example, intracellular accumulation of PA results in
metabolic production of lipids that can be deleterious, such as diacylglycerol (DAG) and
ceramides, which activate downstream PKC isoforms (Figure 4; Palomer et al., 2018). PKC
inhibits insulin-phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT) signalling via
phosphorylation of serine residues on insulin receptor substrate (IRS), leading to insulin resistance
(Coll et al., 2008; Wali et al., 2006). PA overload is linked to negative outcomes including ER
stress, apoptosis, and type 2 diabetes through the DAG and ceramide pathways (Wali et al., 2006).
In reproduction, higher concentrations of PA in follicular fluid and culture media are associated
with morphologically poor cumulus-oocyte complexes (Sinclair et al., 2008), lower fertilization
rates of bovine oocytes (Aardema et al., 2011), and lower hatching rates of bovine blastocysts
(Cagnone & Sirard, 2014). Other saturated fatty acids, such as stearic acid (18:0), elicit similar
effects on early embryo development (Fayezi et al., 2018).
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Figure 4. Proposed mechanisms of intracellular PA metabolism and effects.
Upon entry into the cell, PA is metabolized into lipid molecules including DAG and ceramides.
These intermediates initiate downstream PKC signaling, which inhibits the insulin-PI3K-AKT
pathway, and contributes to ER stress, ROS accumulation, and apoptosis. Figure from (Yousif,
2019; Figure 3). Copyright permission found in Appendix B.

12

In contrast to PA, intracellular accumulation of OA favours the formation of triacylglycerol
(TAG), providing metabolically inert and benign lipid storage (Palomer et al., 2018). Furthermore,
cells exposed to co-treatment of PA and OA incorporated a greater fraction of FFA into TAG
compared with PA alone (Palomer et al., 2018). This mechanism of OA metabolism likely protects
cells from inflammation and, to some extent, prevents the advancement of insulin resistance
(Palomer et al., 2018). Additionally, OA is associated with increased expression of genes involved
in fatty acid oxidation, such as the peroxisome proliferator-activated receptor 𝛾 (PPAR𝛾)
coactivator 1𝛼 (PGC1𝛼), and carnitine palmitoyl transferase 1 (CPT1) (Coll et al., 2008; Lim et
al., 2013; Palomer et al., 2018). PA and OA also have differing effects on reproduction. The
presence of OA in follicular fluid and culture media is associated with higher bovine oocyte quality
(Warzych et al., 2014), better bovine oocyte fertilization rates (Aardema et al., 2011), metabolic
partitioning of saturated FFAs into non-toxic lipids (Aardema et al., 2011; Listenberger et al.,
2001), and reduced detrimental effects on fertilization, cleavage or blastocyst formation compared
with saturated FFAs (Leroy et al., 2005). Mechanisms underlying the contrasting relationships
between PA, OA, and reproductive outcomes likely include metabolic signalling, plasma
membrane fluidity and regulation of oxidative stress (Fayezi et al., 2018).
Our lab has recently shown that exposure to 100 µM PA treatment in vitro significantly reduces
the development of two-cell stage mouse embryos to the blastocyst stage (Yousif et al., 2020).
Additionally, PA treatment was accompanied by increased ER stress mRNA expression and
reduced blastocyst cell number (Yousif et al., 2020). Interestingly, co-treatment with OA (50 µM–
250 µM) reversed the negative effects of PA exposure on embryo development. This included
rescuing blastocyst formation, reducing ROS accumulation and ER stress mRNA expression, and
increasing intracellular lipid droplet formation (Yousif et al., 2020).

1.7 NRF2/KEAP1 Signalling Pathway
To advance our understanding of the mechanisms underlying the effects of PA and OA on
preimplantation embryo development, my research is the first to investigate the NRF2/KEAP1
cellular stress response pathway following PA and OA treatment of mouse preimplantation
embryos. Nuclear factor erythroid 2-related factor 2 (NRF2) is a nuclear transcription factor
(Suzuki & Yamamoto, 2015). It is a member of the erythroid 2-related family, which are part of
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the cap-n-collar subfamily of basic leucine zipper transcription factors (Huang et al., 2015; Suzuki
& Yamamoto, 2015). NRF2 acts as a master coordinator of cytoprotective and cellular stress
responses, including the antioxidant response pathway (Huang et al., 2015). Constitutive
expression and degradation of NRF2 mediates basal activity levels and maintains a low level of
target gene expression to preserve cellular homeostasis (Canning et al., 2015). When activated,
NRF2 provides a major inducible response to environmental stressors, and is linked to hundreds
of downstream target genes involved in a wide range of cytoprotective functions (Suzuki &
Yamamoto, 2015; Tonelli et al., 2018). In addition to antioxidant systems, NRF2 is involved in
autophagy, stem cell quiescence, pathways of the UPR, and even mitochondrial bioenergetics
(Tonelli et al., 2018). Consequent of the importance of NRF2, it is tightly regulated at the
transcriptional, translational and post-translational levels, including regulation of protein stability
and binding partners (Tonelli et al., 2018).
Given how widely NRF2 is implicated in cellular processes, it is unsurprising that transcription of
Nrf2 (NRF2) is regulated by numerous signalling pathways. Xenobiotics can induce Nrf2
transcription via aryl hydrocarbon receptor (AhR) (Miao et al., 2005; Tonelli et al., 2018). AhR
binds as a heterodimer with its counterpart, AhR nuclear translocator (Arnt), to regions in the Nrf2
sequence that respond to xenobiotics (Tonelli et al., 2018). Inflammatory molecules may also
induce Nrf2 transcription via nuclear factor kappa-light-chain-enhancer of activated B cells (NF𝜅B) binding to a specific site in the Nrf2 promoter (Tonelli et al., 2018). The PI3K-AKT and Notch
signalling pathways are also implicated in augmenting Nrf2 transcription via direct interactions
between pathways (Mitsuishi et al., 2012; Tonelli et al., 2018; Wakabayashi et al., 2014). In
addition to regulation by other pathways, Nrf2 contains antioxidant response element (ARE)related sequences in its promoter region, which creates a positive feedback loop to further increase
transcription whenever Nrf2 transcription is induced (Tonelli et al., 2018). Nrf2 is also modified
post-transcriptionally by sequence-specific binding of miRNAs that cause negative regulation, and
through alternative splicing that can change NRF2 protein stability (Tonelli et al., 2018). Although
regulation at every level is important to its availability, function, and activity, NRF2 is primarily
regulated via its proteasomal degradation (Tonelli et al., 2018).
Kelch-like ECH-associated protein 1 (KEAP1) is the primary regulatory protein of NRF2 that is
also involved in sensing cellular stress (Canning et al., 2015; Suzuki & Yamamoto, 2015). KEAP1,
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a member of the Broad complex, Tramtrack, and Bric-a-Brac (BTB)-containing domain protein
family, is an adaptor subunit of Cullin 3-based E3 ubiquitin ligase and forms a Cullin–Really
Interesting New Gene (RING) E3 ligase complex to mediate its effects (Canning et al., 2015;
Cullinan et al., 2004; Suzuki & Yamamoto, 2015). Essentially, KEAP1 forms a bridge between
NRF2 and Cullin 3-based E3 ligase, and directs ubiquitin substrate binding (Cullinan et al., 2004;
Figure 5A).
KEAP1 binds to highly conserved regions contained in the NRF2 protein, known as NRF2-ECH
homologous (Neh) domains; specifically, Neh2 mediates KEAP1 binding to NRF2 (Canning et
al., 2015). Two particular Neh2 domains, DLG and ETGE, are responsible for mediating the NRF2
interaction with KEAP1 (Tonelli et al., 2018; Figure 5B). Another domain, Neh1, provides the
NRF2 protein with an essential interaction for its function: heterodimerization with small
musculoaponeurotic fibrosarcoma oncogene homolog (Maf) proteins (Canning et al., 2015). The
importance of Neh1—and, by extension, small Maf heterodimerization—is highlighted by its high
sequence conservation across species (Tonelli et al., 2018). Other regions, such as Neh6, are
targeted by E3 ubiquitin ligase for degradation of NRF2 (Canning et al., 2015; Tonelli et al., 2018).
The Neh7 domain aids in repressing NRF2 transcriptional activity via physical association with
the retinoid X receptor 𝛼 (Tonelli et al., 2018).
Under normal oxidative conditions, KEAP1 forms a complex with NRF2 in the cytoplasm which
promotes the ubiquitylation and proteasomal degradation of NRF2 (Cullinan et al., 2004). In this
homeostatic state, two KEAP1 proteins are bound to the Neh2 domain of NRF2 via the DLG and
ETGE sequences (Tonelli et al., 2018). Sequestration of cytoplasmic NRF2 is necessary to prevent
premature nuclear accumulation and inducible expression of NRF2 cytoprotective systems
(Cullinan et al., 2004; Suzuki & Yamamoto, 2015). Under cellular stress conditions, ROS and
electrophiles interact with cysteine residues on the KEAP1 protein structure to alter the
NRF2/KEAP1 interaction and release NRF2 from the complex (Suzuki & Yamamoto, 2015).
Electrophilic modifications of cysteine residues on KEAP1 inhibits ubiquitin ligase activity,
rendering the KEAP1–E3 ligase complex inactive (Suzuki & Yamamoto, 2015). Unencumbered
NRF2 then translocates to the nucleus to mediate its function as a transcription factor.
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Figure 5. (A) KEAP1 (orange) forms a complex with NRF2 (red) and Cullin 3-based E3 ligase
(green). (B) Schematic showing structural domains of Nrf2 and Keap1 proteins.
(A) NRF2 interacts with KEAP1 via its Neh2 domain, forming a complex. The interaction between
KEAP1 and Cullin 3-based E3 ligase targets NRF2 for ubiquitylation and proteasomal
degradation. (B) Figures from (Canning et al., 2015) where (A) Figure 4b and (B) Figure 1.
Copyright permission found in Appendix B.
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In the nucleus, NRF2 heterodimerizes with small Maf proteins, forming a complex that binds to
AREs in the promoter regions of target cytoprotective genes and upregulates their expression
(Suzuki & Yamamoto, 2015; Figure 6). Of the remaining Neh domains, Neh3 contains
transactivation activity, and works together with Neh4 and Neh5 domains to activate transcription
of NRF2 target genes (Tonelli et al., 2018). After heterodimerization, the NRF2-small Maf
complex binds to AREs in promoter regions with sequence-specific affinity (5’-TGACXXXGC3’) (Tonelli et al., 2018). In this way, NRF2 is capable of inducing hundreds of genes containing
ARE sequences in their promoter regions.
Given its importance in cellular homeostasis, it is not surprising that NRF2/KEAP1 signalling is
widely implicated in health and disease. The functions of NRF2 target genes are broad, including
metabolism of drugs, amino acids and minerals, as well as drug excretion, cell proliferation,
autophagy, and mitochondrial function among others (de la Vega et al., 2018; Dodson et al., 2019;
Hayes & Dinkova-Kostova, 2014). NRF2 is a prominent candidate in cancer research due to its
complex and context-dependent effects; the recent body of evidence points to the robust
cytoprotective function of NRF2 being a hallmark of tumorigenesis, due to increased proliferation
and decreased cell death in cancer cells (de la Vega et al., 2018). Research shows that NRF2
activation plays a role in suppressing arthritis (Su et al., 2018) and dimethyl fumarate, an NRF2
activator, is approved as a therapeutic to treat multiple sclerosis (Dodson et al., 2019).
Additionally, NRF2 is implicated in Type 2 diabetes, other neurodegenerative diseases such as
Alzheimer’s and Parkinson’s disease, and cardiovascular diseases (David et al., 2017; Dodson et
al., 2019; Osama et al., 2020; Petrillo et al., 2020; Reuland et al., 2013). NRF2/KEAP1 signalling
impacts a wide range of physiological processes through the stress response, which includes effects
on embryo development.

17

Figure 6. Schematic representation of NRF2/KEAP1 signalling pathway under homeostatic
and cell stress conditions.
Under normal conditions, KEAP1 (pink) forms a complex with NRF2 (blue) in the cytosol, and
promotes the ubiquitylation and degradation of NRF2. Under cellular stress conditions, reactive
oxygen species interact with cysteine residues on KEAP1 to alter the interaction and free NRF2
from the complex. NRF2 then translocates into the nucleus where it heterodimerizes with small
Maf proteins, and binds to antioxidant response elements to upregulate the expression of
cytoprotective genes. Figure from (Hiebert & Werner, 2019). Copyright permission found in
Appendix B.
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1.8 NRF2/KEAP1 Signalling in Embryo Development
Regulation of oxidative homeostasis and stress responses is critical for proper embryo
development (Sant et al., 2017; Truong et al., 2016). ROS is one of the best characterized stressors
during preimplantation embryo development (Amin et al., 2014; Truong et al., 2016). In vivo
preimplantation development occurs under low oxygen conditions of approximately 2–8% in the
reproductive tract, in contrast to atmospheric oxygen levels, which are approximately 20%
(Truong et al., 2016).
Preimplantation embryo development is very sensitive to oxidative insults and reaps the benefits
of maintaining a hypoxic or reduced O2 environment (Matsumaru & Motohashi, 2019). In fact,
exposure to 20% oxygen negatively impacts embryo development, likely through production of
ROS (Gardner & Lane, 2005; Rinaudo et al., 2006; Truong et al., 2016). ROS accumulation
induces stress and produces various deleterious effects including DNA damage, delayed cleavage
divisions, and apoptosis (Burton et al., 2003; Truong et al., 2016). The embryo is equipped with
systems to combat stress, and functional gene analysis has revealed that NRF2 is a dominant
response pathway (Amin et al., 2014; Gad et al., 2012).
Activated NRF2 coordinates effects on downstream targets, including genes for antioxidant
enzymes, which combat oxidative stress when upregulated (Truong et al., 2016). The beneficial
effect of downstream antioxidants is supported by evidence that supplementing culture with
exogenous antioxidants improves blastocyst development under 20% oxygen conditions (Truong
et al., 2016). Bovine blastocysts with higher developmental competence show higher NRF2
expression, compared with lower NRF2 expression in blastocysts with lower developmental
competence (Amin et al., 2014). In zebrafish embryos, the glutathione antioxidant system is the
robust protector against pro-oxidative conditions, and proper deployment of glutathione signalling
relies on biosynthesis by NRF2 and its family members (Sant et al., 2017). Similarly, treatment of
embryos with 3H-1,2-dithiole-3-thione (D3T), an NRF2 inducer, increases downstream activity of
antioxidant and phase II enzymes to protect embryos from the effects of oxidation (Matsumaru &
Motohashi, 2019).
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Although NRF2 undoubtedly has an important protective role in redox homeostasis, evidence
suggests that the whole NRF family shoulders this responsibility. One study indicated that Nrf2-/knockout is not lethal during embryogenesis, and mice show no morphological abnormalities,
possibly due to compensatory NRF1 activity (Itoh et al., 1997; Matsumaru & Motohashi, 2019).
However, Nrf2-/- mice show follicular alterations, greater sensitivity to inflammation in utero,
increased placental oxidative stress, inflammation, cell death, and increased susceptibility to
preterm birth (Hu et al., 2006; Matsumaru & Motohashi, 2019; Sussan et al., 2017). Another study
found a link between neural tube defects and lower expression and activity of the NRF2 signalling
pathway, suggesting that NRF2 is required for proper development (Liu et al., 2018). On the other
hand, increasing NRF2 activation can be deleterious during development; Keap1-/- knockout mice
die before weaning due to their complete inability to negatively regulate NRF2 (Matsumaru &
Motohashi, 2019).
Overall, NRF2 has a complex role in development. It is a major regulator of redox homeostasis
and plays a protective role through the promotion of antioxidants; however, overexpression of Nrf2
is undesirable, creating a double-edged sword. Additionally, Nrf2 knockout is not fatal, suggesting
that there are other mechanisms in play. Nevertheless, lack of NRF2 signalling is associated with
other developmental abnormalities that support its importance during preimplantation embryo
development.

1.9 Downstream NRF2 Constituents
Activated NRF2 regulates a large number of downstream constituents, including the antioxidant
enzymes catalase (Glorieux et al., 2015; Weydert & Cullen, 2010), superoxide dismutase (SOD1)
(Weydert & Cullen, 2010; Yan et al., 2019), and glutathione peroxidase (GPX1) (Jerotic et al.,
2019; Weydert & Cullen, 2010; W. Yang et al., 2015). The enzymes Catalase, SOD1 and GPX1
play a critical role in removing harmful oxidants as three of the most common antioxidant enzymes
(Wang et al., 2017). The enzyme SOD1, also known as Cu/ZnSOD, catalyzes the conversion of
harmful superoxide species into oxygen and the more stable molecule hydrogen peroxide
(Eleutherio et al., 2021). Another SOD isoform (SOD2) exists, but SOD1 dominates the nuclear
and cytoplasmic cellular compartments, where NRF2 and KEAP1 reside (Wang et al., 2017).
Catalase mediates its effects by dismutating hydrogen peroxide (H2O2), a common reactive oxygen
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species, into water and oxygen (Glorieux et al., 2015). GPX1 is also a major enzyme responsible
for clearing hydrogen peroxide from the cellular environment and suppresses H2O2-induced
apoptosis (Weydert & Cullen, 2010). SOD1, Catalase and GPX1 work together—with other
antioxidants—to maintain the delicate balance of redox homeostasis in the cell (Figure 7).
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DNA,

Figure 7. Schematic representation of ROS generation and dismutation by cellular antioxidant
enzymes Sod1, Gpx1 and Catalase.
Sod1 catalyzes the dismutation superoxide into oxygen and hydrogen peroxide. Hydrogen
peroxide is then neutralized via Catalase or Gpx1 enzymatic activity. Figure adapted from (Wang
et al., 2017). Copyright permission found in Appendix B.
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While gene expression of Catalase, Sod1 and Gpx1 are important for their availability in the cell,
enzymatic activity levels are especially important (Weydert & Cullen, 2010). Supplementation of
culture media with antioxidants has shown beneficial effects for preimplantation embryo
development (Truong et al., 2016), including increased blastocyst viability after cryopreservation
when antioxidants are included in vitrification solutions (Truong & Gardner, 2020). Even prior to
fertilization, research has shown the importance of antioxidant enzymes in ovarian function, with
disruptions in antioxidant systems potentially leading to pathologies and downstream effects on
development (Wang et al., 2017). However, a critical balance must be maintained; ROS at low
levels are still required for ovulation (Wang et al., 2017).
The antioxidant response pathways play an important cytoprotective role against oxidative stress
conditions (Nguyen et al., 2009), especially during preimplantation development when the embryo
is sensitive to insults and stress (Truong et al., 2016). Interestingly, one study has shown that PA
downregulates the expression of antioxidant response genes, including antioxidant enzymes, in
skeletal muscle cells (Guo et al., 2020). Increased antioxidant presence mitigates PA-induced
apoptosis and growth inhibition (Beeharry et al., 2003), and OA produces similar protective effects
against PA-induced stress during preimplantation embryo development (Yousif et al., 2020).
Melatonin, an important endogenous hormone with antioxidant and free radical scavenging
capabilities, ameliorates PA-induced granulosa cell apoptosis in mice (Chen et al., 2019). In
general, melatonin shows beneficial effects on female fertility, including follicular growth, oocyte
maturation and preimplantation embryo development (Chen et al., 2019).
The relationship between OA and antioxidant enzymes is complex across different organs and
tissues. For example, while OA shows some beneficial effects for fertility, it also contributes to
hepatic steatosis in the liver (Yang et al., 2018). One study shows that treatment with antioxidants
effectively reduces the accumulation of triglycerides and lipid droplets in hepatocytes, as well as
mitigating ROS accumulation and apoptosis (Yang et al., 2018).

1.10 Rationale
Among the numerous physiological roles of the NRF2/KEAP1 pathway are its effects on
preimplantation embryo development, which play an important role during this vulnerable
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developmental period. Evidence shows that inhibition of NRF2 is associated with cell cycle arrest
in mouse preimplantation blastomeres, and inhibiting NRF2 in the zygote prevents embryo
development entirely (Lin et al., 2018). NRF2 is also implicated in onset of preeclampsia, where
NRF2 deficiency showed benefits for maternal and fetal survival, and recovered the suppression
of angiogenesis in mice (Nezu et al., 2017). Compounds such as melatonin and quercetin, a plantderive flavonoid, potentially interact with the NRF2/KEAP1 pathway during early development,
with beneficial effects on redox homeostasis and embryo outcomes (Khadrawy et al., 2020; Kim
et al., 2019). Regulation of ER stress and mitochondrial ROS during preimplantation development
is essential for proper development to occur (Truong et al., 2016). Additionally, NRF2 is a target
of PERK signalling via kinase activity, which is one of the major arms of the UPR (Digaleh et al.,
2013). Cellular defence systems are complex, responding to a variety of stimuli, including lipids.
PA and OA have been studied extensively in tissues of the body, where PA generally induces
undesirable outcomes, and OA opposes them with beneficial outcomes (Chu et al., 2019; Hao et
al., 2020; Meng et al., 2019; Ricchi et al., 2009; Yang et al., 2018). Previous research shows that
PA is capable of inducing ER stress pathway expression (Yousif et al., 2020). Taken together,
evidence suggests that NRF2/KEAP1 signalling can modulate and mitigate ER stress, and perhaps
also the consequences of exposure to high FFA levels during preimplantation development.
Fertility challenges faced by obese women continue to become more pressing as this patient
population continues to increase in size. It is crucial to understand how the physiology of obesity
affects reproductive health in the context of fertility medicine and ARTs, including the impact of
abundant FFAs such as PA and OA on various aspects of embryo development. Maternal obesity
and lipotoxicity present unique environmental stressors for early in vivo development, challenging
the ability of the embryo to adapt to its environment, and the NRF2/KEAP1 pathway is a prominent
responder in such times of cellular stress.
My research project and thesis aim to provide a link between exposure to elevated free fatty acids,
namely PA and OA, in embryo culture and their impact on the NRF2–KEAP1 antioxidant response
pathway during mouse preimplantation embryo development.
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1.11 Hypothesis
My primary hypothesis is that treatment of mouse preimplantation embryos with PA activates the
NRF2/KEAP1 antioxidant response pathway, and that pathway activation is alleviated by cotreatment with OA.

1.12 Objectives
My experiments in this thesis will address the following objectives:
1)

Define protein localization and mRNA abundance patterns of NRF2 and KEAP1
throughout in vitro mouse preimplantation embryo development

2)

Define the effects of PA treatment on NRF2/KEAP1 subcellular protein localization,
and determine whether co-treatment with OA reverses these effects during mouse
preimplantation embryo development.

3)

Determine the effects of PA and OA treatments on downstream antioxidant relative
mRNA levels of the NRF2/KEAP1 pathway, including Catalase, Sod1 and Gpx1
during preimplantation embryo development.
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Chapter 2: Materials & Methods
2.1 Animal Ethics Approval
All experiments used CD-1 mice sourced from Charles River Laboratories (Saint-Constant, QC).
Mice were handled in accordance with the Canadian Council on Animal Care, as well as complying
with Animal Care and Use Policies at Western University. Experiments are registered to Protocol
#2018-075 under Dr. Andrew J. Watson. Mice were housed in conventional housing with a 12hour light/dark cycle and access to food ad libitum. Ethics approval can be found in Appendix A.

2.2 Mouse Superovulation Protocol
Female CD-1 mice (4–6 weeks old) were super-ovulated by intraperitoneal (IP) injections of 5.0
international units (IU) of pregnant mare’s serum gonadotropin (PMSG, Merck Animal Health,
Canada) to stimulate follicular growth. PMSG injections were followed 48 hrs later by the same
females receiving IP injections of 5.0 IU of human chorionic gonadotropin (hCG, Merck Animal
Health, Canada) to stimulate increased ovulation. After hCG injections, female mice were placed
in individual cages with male CD-1 mice overnight for natural mating. For all experiments,
injections were performed between 10am and noon. The following morning after mating, female
mice were visually assessed for the presence of vaginal plugs which indicated successful mating.
Female mice that did not mate successfully were indicated using a black marker on their tails.
After visual plug assessment, all female mice were returned to their original colony cages
overnight.

2.3 Flushing Mouse Two-Cell Embryos
The morning following plug assessment, 46 hours post-injection of hCG, all female mice were
sacrificed using CO2 euthanasia. Mice with seminal plugs were dissected to isolate their oviducts,
the small tubular organ between the ovary and uterine horn. Oviduct pairs (one pair from each
female mouse) were placed in a culture dish containing drops of M2 embryo flushing medium
(Sigma-Aldrich, Canada) warmed to 37°C. Culture temperature was maintained using a warm
water bottle and heating lamp. Syringes (3 mL) of M2 flushing medium were also warmed to 37°C
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for use in embryo flushing. Under a light microscope, mouse two-cell embryos were flushed from
the oviducts using warmed syringes, needle (30Gx1/2), and M2 flushing medium. Two-cell
embryos were collected into 50 µL of potassium simplex optimization media with amino acids
(KSOMaa Evolve, Zenith Biotech, Canada). Embryos were washed thrice in subsequent 50 µL
drops of KSOMaa to eliminate debris from oviducts and the flushing process. After washing,
embryos were distributed into treatment groups that were set up for the given experiment. Embryos
were cultured in 20 µL treatment drops under mineral oil, with up to 20 embryos in each drop.

2.4 Flushing Mouse One-Cell Embryos
The same morning of visual plug assessment, approximately 22–24 hours post-injection of hCG,
female mice were sacrificed using CO2 euthanasia. Mice with seminal plugs were dissected to
isolate their oviducts, and oviduct pairs were placed in a culture dish containing drops of M2
flushing medium warmed to 37°C. Culture temperature was maintained using a warm water bottle
and heating lamp. Syringes (3 mL) of M2 flushing medium were also warmed to 37°C. Under a
light microscope, one-cell embryos were extracted from oviducts using a combination of
techniques. The most effective technique was to tear open the swollen portion of the oviduct where
one-cell embryos had collected, allowing them to escape into the M2 medium. This was followed
by the secondary method of flushing the oviduct using warmed syringes, needle (30Gx1/2), and
M2 flushing medium to ensure that all one-cell embryos exited the oviduct. Hyaluronidase solution
was prepared to a final concentration of 0.03% of human recombinant hyaluronidase (SigmaAldrich, Canada) in M2 flushing medium, then filter sterilized into a syringe (10 mL). After onecell embryos were flushed from oviducts, they were transferred to hyaluronidase solution for 10–
20 seconds to accomplish denudation of surrounding cumulus cells.
After denudation, one-cell embryos were collected into 50 µL of KSOMaa, then washed thrice in
subsequent 50 µL drops of KSOMaa to eliminate debris. After washing, embryos were distributed
into treatment groups that were cultivated for the given experiment. Embryos were cultured in 20
µL treatment drops under mineral oil, with up to 20 embryos in each drop.
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2.5 FFA Culture Treatment Preparation
Fatty acid carrier, bovine serum albumin (BSA, Sigma-Aldrich, Canada), was dissolved overnight
in phosphate-buffered saline (PBS) to a final concentration of 20% BSA solution, then filter
sterilized. Stock BSA solution was used for conjugation in PA (Sigma-Aldrich, Canada) or OA
(Sigma-Aldrich, Canada) solution.
Stock solutions were created by solubilizing PA and OA, separately, in RNase-free water and
sodium hydroxide (NaOH) at 70°C. Stock solutions had concentrations of 20 mM. Then, the stock
solution was conjugated to BSA in a 2:1 ratio to produce a final solution (PA or OA) with a
concentration of 500 µM. After preparation, conjugated solutions were stored at 4°C for later use
in embryo culture treatment groups.

2.6 Embryo Culture Conditions
Collected two-cell stage embryos were washed and placed into culture groups. Treatment
conditions were prepared as follows:
1) BSA in KSOMaa as the control (20% BSA in KSOMaa using 2:3 volume ratio)
2) 100 µM PA (PA stock in 20% BSA and KSOMaa using 1:1:3 volume ratio)
3) 100 µM OA (OA stock in 20% BSA and KSOMaa using 1:1:3 volume ratio),
4) 100 µM PA + 100 µM OA (PA and OA stocks in KSOMaa using 1:1:3 volume ratio)
Culture dishes each contained 3 treatment drops of 20 µL, covered by embryo-grade mineral oil
(Sigma-Aldrich). Each culture drop contained up to 20 embryos for a maximum density of 1
embryo/µL. Based on individual experimental needs, embryos were cultured for 0 hrs, 18 hrs, 24
hrs or 48 hrs at 37°C under an atmosphere of 5% O2, 5% CO2, and 90% N2.

2.6.1 Effects of 18 & 24 hr PA and OA treatment on NRF2/KEAP1 in
preimplantation embryos
Two-cell mouse embryos were cultured in KSOMaa containing BSA, 100 µM PA, 100 µM OA,
or 100 µM PA + 100 µM OA treatments for 0 hrs, 18 hrs and 24 hrs at 37°C under an atmosphere
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of 5% O2, 5% CO2, and 90% N2. The BSA group was used as a control for embryo development.
All embryos were collected from treatment groups for further analysis.

2.6.2 Effects of 48-hour PA and OA treatment on NRF2/KEAP1 in mouse
preimplantation embryos
Two-cell mouse embryos were cultured in KSOMaa containing BSA, 100 µM PA, 100 µM OA,
or 100 µM PA + 100 µM OA treatments for 48 hrs at 37°C under an atmosphere of 5% O2, 5%
CO2, and 90% N2. The BSA group was used as a control for embryo development. All embryos
were collected from treatment groups for further analysis.

2.6.3 Developmental series culture and collection of preimplantation
embryos
Embryos were cultured such that they could be collected at one-cell, two-cell, four-cell, eight-cell,
morula and blastocyst stages of development. One-cell mouse embryos were collected as described
in section 2.4. A subset of two-cell stage embryos were collected as described in section 2.3. The
remaining two-cell stage embryos were cultured in KSOMaa drops, covered by embryo-grade
mineral oil, at 37°C under an atmosphere of 5% O2, 5% CO2, and 90% N2. Four-cell stage embryos
were collected at approximately 18–24 hrs of culture. Eight-cell stage embryos were collected at
approximately 24–30 hrs of culture. Morula stage embryos were collected at approximately 30–
36 hrs of culture. Finally, blastocyst stage embryos were collected at approximately 48 hours of
culture. All embryos were collected for further analysis.

2.7 Developmental Stage Assessment
At the end of the culture period—from 0 to 48 hours, depending on the individual experiment—
embryos were visually examined under light dissecting microscopy to determine their
developmental stage. The proportion of embryos at each developmental stage in each treatment
group was recorded. Embryos were categorized as being 2-cell, 4-cell, 8-cell, morulae, or
blastocysts. Cleavage stage embryos, or those between 2- and 8-cell stage, were identified based
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on the number of distinct blastomeres. Morulae were identified based on the presence of
compacted blastomeres and the lack of a fluid-filled cavity, and blastocysts were identified as
embryos with a visible fluid-filled cavity. After developmental assessment, embryos were either
frozen at -80°C for mRNA transcript analyses or fixed for immunofluorescence labelling and
confocal microscopy.

2.8 RNA Extraction and Reverse Transcription
Frozen embryo groups (-80°C) were thawed on ice. Total RNA was extracted from each embryo
treatment group using a PicoPure RNA Isolation Kit (ThermoFisher Scientific) and the
manufacturers’ protocol. Exogenous luciferase mRNA (0.0025 pg/embryo, Promega) was added
to each sample for the purposes of using it as a reference gene during end-point PCR and delta
delta Ct analysis. The use of DNase 1 (RNA free DNase kit, Qiagen) was inserted as an additional
step to eliminate genomic DNA from embryo samples. Obtained RNA was reverse transcribed
into cDNA using SensiScript Reverse Transcriptase Kit (Qiagen). cDNA was diluted to 1
embryo/µL using RNase-free water, and stored at -20°C if not used immediately.

2.9 cDNA Assessment via Polymerase Chain Reaction (PCR)
The quality of the cDNA synthesis protocol was confirmed by performing PCR for luciferase and
histone H2A transcripts. Components of each PCR reaction mix were as follows: 2.5 µL of 10X
PCR buffer, 0.75 µL of 50 mM MgCl2, 0.5 µL of 10 mM dNTPs, 0.1 µL of 100 µM forward
primer, 0.1 µL of 100 µM reverse primer, 0.1 µL Taq polymerase, and 19.95 µL RNase-free water.
cDNA from each sample was added to each reaction mix (1 µL), except for the positive and
negative controls, which received 1 µL cDNA from an untreated embryo pool, and 1 µL of RNasefree water, respectively.
The cycling conditions for luciferase and H2A were: 94°C for 2 minutes, 44 cycles of 94°C for 30
seconds, then either 59°C (luciferase) or 61°C (H2A) for 30 seconds, followed by 72°C for 1
minute, and finally 72°C for 10 minutes. The thermocycler decreased to an endpoint of 4°C until
sapmles were transferred to 4°C storage. PCR products for luciferase and H2A in each sample
were run on 2% agarose gel containing ethidium bromide in 1X TAE running buffer at 115V for
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approximately 45 minutes. Gels were imaged under trans UV light to visualize the luciferase and
H2A bands of predicted size for each sample.

2.10 Quantitative RT-PCR (qRT-PCR) to Assess Relative
Transcript Abundance
Quantitative PCR was performed to assess the effects of embryo culture treatments on transcripts
of interest using TaqMan probes (ThermoFisher Scientific) in a 384-well plate. TaqMan primers
for mouse Nrf2 (#Mm00477786_m1 Nfe2l2), Keap1 (#Mm00497268_m1 KEAP1), Gpx1
(#Mm00656767_g1 Gpx1), Catalase (#Mm00437992_m1 Cat), and Sod1 (#Mm01344233_g1
Sod1) were used in qRT-PCR experiments. Master mixes were prepared for each target gene
(including luciferase) based on the number of wells required for the individual experiment. Each
well required 20 µL of master mix, with the volume divided as follows: TaqMan Gene Expression
2X Mastermix (0.5*total volume), TaqMan primer of interest (0.05*total volume), and RNase-free
water (0.4*total volume). Volumes were multiplied by the total number of wells required for each
gene to calculate the total required. Once master mix components were combined, they were
vortexed to ensure even distribution of components.
Master mixes were aliquoted into Eppendorf tubes (Fisher Scientific) for each sample. Each tube
received 62.7 µL of master mix, followed by 3.3 µL of cDNA (1 embryo/µL) from the
corresponding sample. These mixtures were vortexed, then each was plated in triplicate on the
384-well plate by aliquoting 20 µL into each well. For each gene, a non-transcript control was
included, which was composed of master mix and RNase-free water instead of cDNA. The qRTPCR plate was sealed using a clear adhesive cover, and centrifuged at 2000 rpm for 2 minutes.
qRT-PCR was performed using a CFX384 TouchTM Real-Time PCR Detection System (BioRad,
Canada). Thermocycling conditions proceeded as follows: 5 minutes at 95°C (AmpliTaq GOLD
DNA polymerase activation), followed by 50 cycles of 15 seconds at 95°C (denaturation) and 1
minute at 60°C (annealing and extension). Ct values were obtained from BioRad CFX Manager
3.1 (BioRad, Canada) and relative transcript abundance determined using the delta-delta Ct
method. RNA extraction, reverse transcription and qRT-PCR protocols were repeated (N=3) with
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biologically distinct embryo pools collected from unique batches of superovulated and mated
female CD-1 mice.

2.11 Indirect Immunofluorescence Staining
Following in vitro embryo culture—from 0 to 48 hours, depending on the individual experiment—
and developmental assessment, embryos were processed for immunofluorescence labelling.
Embryo pools from each treatment group were fixed in 2% paraformaldehyde prepared in PHEM
buffer for 30 minutes in glass-bottomed dishes, then transferred to PHEM buffer for storage at 4°C
until further use.
Fixed embryos were washed in PBS for 20 minutes, then incubated in Donkey blocking buffer for
1 hour, consisting of: 5% Normal Donkey Serum (Sigma-Aldrich), 0.1% Triton X (Fisher
BioReagents®), and 0.02% NaN3 (Sigma-Aldrich) in PBS. Donkey blocking buffer was used to
block non-specific antibody binding during the incubation steps. Embryo pools were then washed
with antibody dilution buffer for 20 minutes, consisting of: 0.5% Normal Donkey Serum, 0.05%
Triton X, and 0.02% NaN3 in PBS.
Embryos from each treatment group were incubated in the presence of primary antibodies as
required for each experiment. In experiments investigating NRF2 localization, embryos were
incubated with anti-NRF2 antibody (#137550, Abcam) at a dilution of 1:100, or in antibody
dilution buffer (control). In experiments investigating KEAP1 localization, embryos were
incubated with anti-KEAP1 antibody (#PA5-99434, Invitrogen) at a dilution of 1:100, or in
antibody dilution buffer (control). Embryos were incubated in primary antibodies overnight at 4°C,
then washed thrice in antibody dilution buffer for 20 minutes each. The washes were followed by
secondary

antibody

incubation

with

AlexaFluor

488

(Donkey

anti-rabbit,

Jackson

ImmunoResearch) at a dilution of 1:400 for 1 hour in a 37°C incubator. The same secondary
antibody was used in all experiments, because both primary antibodies were raised in rabbits.
Next, embryo samples were counterstained for detection of cell nuclei and actin cytoskeleton.
Embryos were incubated with Rhodamine Phalloidin for filamentous actin at a dilution of 1:20
(P1951, Millipore Sigma) and 4′,6-diamidino-2-phenylindole (DAPI) for nuclei at a dilution of
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1:1000 (D9542, Sigma-Aldrich) at 37°C for 1 hour. Embryos were washed twice with antibody
dilution buffer for 20 minutes each. Finally, glass-bottomed culture dishes (Avantor VWR) were
used to mount embryos for confocal imaging. Each treatment dish contained two 5 µL drops of
KSOMaa, into which embryos from treatment groups were equally divided, and drops were
covered with embryo-grade mineral oil. The same antibody labelling protocol was repeated (N=3)
for each primary antibody with biologically distinct embryo pools collected from unique batches
of superovulated and mated female 4–6 week old CD-1 mice.

2.12 Confocal Microscopy
Embryos

from

all

treatment

groups

were

examined

using

confocal

microscopy.

Immunofluorescence images were obtained on a Zeiss LSM 800 AiryScan confocal microscope
located within the Schulich Imaging Core Facility. Images were taken using the 10x and 25x
(water) objectives. Z-stacks were performed for embryos in each treatment such that 10 slices of
equal thickness were imaged through each embryo. On the microscope, laser master gain and
intensity settings were kept constant when visualizing embryos from the same experiment.

2.13 Confocal Image Analysis
Immunofluorescence images from embryos in each experiment were evaluated using FIJI (ImageJ)
software. Employing Rhodamine Phalloidin and DAPI staining, the total number of cells in each
embryo were counted. Then, depending on the experiment, other parameters were assessed.
For NRF2 localization experiments, the number of cells with NRF2-fluorescent nuclei were
counted for each embryo, defined as co-localization between the NRF2 and DAPI channels. Cell
counts were used to calculate the mean percentage of NRF2-positive nuclei for each treatment.
For KEAP1 localization experiments, the number of cells with KEAP1 fluorescence were counted
for each embryo, defined as visual presence of KEAP1 staining inside cell boundaries. Cell counts
were used to calculate the mean percentage of KEAP1-positive cells for each treatment. Cell
counting for all experiments was performed using Z-stack images.
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2.14 Statistical Analyses
GraphPad Prism 9 was used to perform all statistical analyses. For immunofluorescence imaging
studies, a biological replicate was defined as a single embryo within a treatment group. For
developmental stage assessments and qRT-PCR gene expression analyses, a biological replicate
was defined as a single embryo pool from a distinct group of mice. All statistical tests employed a
significance threshold of p<0.05.
Development stage assessment data was used to calculate the percentage of embryos at each
developmental stage—one-cell, two-cell, 4-cell, 8-cell, morula, and blastocyst—in each treatment
group. Within each treatment group, developmental stage frequency was compared using one-way
analysis of variance (ANOVA) with Tukey’s post-hoc test for multiple comparisons. Blastocyst
frequencies were compared between treatment groups using one-way ANOVA with Tukey’s posthoc test.
Relative mRNA abundance was determined from Ct values using the delta-delta Ct method.
Quantification of relative transcript abundance for each gene was followed by one-way ANOVA
and Tukey’s post-hoc test to compare between treatment groups.
For immunofluorescence image analysis, percentage of NRF2-positive nuclei were compared
between treatment groups using one-way ANOVA with Tukey’s post-hoc test. Similarly,
percentage of KEAP1-positive cells were compared between treatment groups using one-way
ANOVA with Tukey’s post-hoc test.

34

Chapter 3: Results
3.1 Effects of PA and OA treatment on mouse preimplantation
embryo development
Previous research in our lab showed that PA treatment impaired mouse preimplantation embryo
development, while OA co-treatment with PA provides protective counter-effects. I therefore first
set out to confirm these findings to solidify the foundation of my project. For these experiments,
two-cell stage mouse embryos were cultured in KSOMaa medium containing BSA, 100 µM PA,
100 µM OA, or 100 µM PA+OA treatments for 48 hours under 37°C, 5% O2, 5% CO2, and 90%
N2 culture conditions (N=12). At the end of the culture period, embryos were imaged using a
dissecting microscope for visual assessment. PA treatment (100 µM) for 48 hours significantly
decreased mouse blastocyst development frequency in vitro (p<0.0001) while 48 hour treatment
with OA alone and PA+OA in combination did not impair blastocyst development from BSA
(control) levels (Figure 8A). PA-treated embryos achieved significantly lower blastocyst
frequency (15.59±3.68%) compared with BSA control (66.45±5.64%), OA (64.22±3.46%), and
PA+OA (61.83±4.76%) co-treatments. Blastocyst frequencies did not differ significantly between
the BSA, OA, and PA+OA combined groups.
PA treatment resulted in embryo fragmentation and developmental arrest that was visually evident
in microscopy images, indicated by red arrows, compared with BSA, OA and PA+OA images
(Figure 8B). PA-treated embryos exhibited a high incidence of developmental arrest at the 4-cell
(28.26±3.49%) and 8-cell (31.13±4.70%) stages of development (Table 1). Comparatively, the
BSA, OA and PA+OA groups all displayed that less than 6.50±1.40% of embryos arrested at the
4-cell or 8-cell stages. Taken together, PA treatment results in a significantly reduced percentage
of morulae (16.84±2.24%) and blastocysts (15.59±3.68%) than those observed in all other
treatment groups (Table 1).
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Figure 8. PA exposure impairs mouse preimplantation embryo development.
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Figure 8. (A) Blastocyst development frequency (%±SEM) following 48-hour culture in BSA,
PA, OA or PA+OA treatment conditions. Inclusion of 100 µM PA in embryo culture media
significantly impaired mouse embryo development to the blastocyst stage. Mouse two-cell stage
embryos were cultured in vitro in BSA, 100 µM PA, 100 µM OA, or 100 µM PA+OA combination
for 48 hours under 37°C, 5% O2, 5% CO2, and 90% N2 conditions (N=12). PA-treated embryos
showed lower blastocyst frequency (15.59±3.68%) compared with BSA (66.45±5.64%), OA
(64.22±3.46%), and PA+OA (61.83±4.76%) treatments. Data were analyzed using one-way
ANOVA with Tukey’s post-hoc test (****p<0.0001). (B) Red arrows indicate examples of
fragmented/arrested embryos in phase contrast images after 48-hour culture. Inclusion of
100 µM PA in embryo culture media produce developmentally restricted preimplantation embryos
compared to BSA, 100 µM OA, and 100 µM PA+OA combination treatments.
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Table 1. Effects of PA and OA on mouse preimplantation developmental stages.
Table 1. Frequency of embryos reaching each stage of preimplantation development
(%±SEM) following 48-hour culture in BSA, PA, OA or PA+OA treatment conditions.
Inclusion of 100 µM PA in embryo culture media significantly increased the percentage of
embryos arresting between the 4-cell and 8-cell stages of development. Embryos treated with BSA,
OA and PA+OA did not show increased developmental arrest between the 4-cell and 8-cell stages.
Within columns, values denoted by different letters are significantly different, per one-way
ANOVA with Tukey’s post-hoc test (p<0.05).
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3.2 Protein immunolocalization of NRF2/KEAP1 during mouse
preimplantation embryo development
I next characterized NRF2/KEAP1 pathway protein localization and relative mRNA transcript
levels during untreated in vitro mouse preimplantation embryo development (Figures 9–11).
Nuclear NRF2 immunofluorescence protein labelling was consistently detected in all mouse
preimplantation embryo developmental stages (Figure 9A). The 1-cell group displayed the lowest
percentage of NRF2 positive nuclei and blastocysts displayed the highest percentage, with each
intervening developmental stage (2-cell, 4-cell, 8-cell and morula) showing an increase in
percentage of NRF2 positive nuclei per embryo. Blastocysts displayed a significantly higher
percentage of NRF2 positive nuclei (89.76±1.06%) compared to 4-cell embryos (72.61±4.02%;
p<0.05) and 1-cell zygotes (67.92±5.80%; p<0.01). Similarly, morulae showed a significantly
higher percentage of NRF2 positive nuclei (88.97±1.79%) compared to 4-cell (p<0.05) and 1-cell
(p<0.001) zygotes (Figure 9A). The 1-cell, 2-cell, 4-cell and 8-cell groups were not significantly
different from one another.
The percentages of NRF2 positive nuclei can be observed in representative confocal images of
Figure 9B. NRF2 displayed nuclear localization at all stages of preimplantation embryo following
culture in KSOMaa. Interestingly, NRF2 immunofluorescence protein labelling was consistently
not detected in the nucleolus, indicated by a darker area in the middle of the nucleus, in blastomeres
from all stages of mouse preimplantation development.
NRF2 immunofluorescence localization was also consistently detected in the cytoplasm of
blastomeres at all mouse preimplantation embryo developmental stages, though this was not
quantified (Figure 9B). Nuclear and cytoplasmic NRF2 immunofluorescence localization were
observed in both the TE and ICM of blastocysts. Additionally, the immunofluorescence intensity
of NRF2 appears to increase throughout development, becoming brightest in the blastocyst stage
embryos; however, this was not quantified.
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Figure 9. NRF2 protein localization and mean positive NRF2 nuclei at each major stage of
preimplantation embryo development.
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Figure 9. (A) Mean positive NRF2 nuclei (%±SEM) at each major stage of preimplantation
embryo development. Nuclear NRF2 localization frequency increased throughout the stages of
preimplantation embryo development, peaking at the blastocyst stage. Embryos were collected or
cultured in KSOMaa to the 1-cell, 2-cell, 4-cell, 8-cell, morula, and blastocyst stages under 37°C,
5% O2, 5% CO2, and 90% N2 culture conditions (N=26). Percentage of NRF2 positive nuclei was
significantly higher at the morula (88.97±1.79%) and blastocyst (89.76±1.06%) stages compared
with the 1-cell stage (67.92±5.80%) and 4-cell stage (72.61±4.02%). Data were analyzed using
one-way ANOVA with Tukey’s post-hoc test to determine significance (*p<0.05, **p<0.01,
***p<0.001). (B) Immunofluorescence images show NRF2, F-actin and DAPI localization at
each major stage of preimplantation embryo development. Nuclear NRF2 localization is
evident at the 1-cell, 2-cell, 4-cell, 8-cell, morula, and blastocyst stages, assessed via overlap
between NRF2 and DAPI channels. Embryos were blocked for non-specific binding and labelled
with anti-NRF2 1° antibody, followed by incubation with DAPI (nuclei) and Rhodamine
Phalloidin (filamentous actin). Images were captured using an LSM 800 confocal microscope.
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Cytoplasmic KEAP1 immunofluorescence localization was observed in all stages of
preimplantation embryo development (Figure 10A). The mean percentage of KEAP1 positive
cells was consistently above 90% in all embryo stages. The 2-cell embryos displayed a
significantly higher percentage of KEAP1 positive cells (97.85±1.50%) compared with the
blastocysts (91.60±1.00%; p<0.05). The 1-cell, 2-cell, 4-cell, 8-cell, and morula groups were not
significantly different from one another (Figure 10A).
Representative examples of KEAP1 immunofluorescent cells are shown in confocal images from
Figure

10B.

Each

mouse

preimplantation

embryo

stage

is

positive

for

KEAP1

immunolocalization, and KEAP1 is primarily confined to the cytoplasm of each blastomere.
KEAP1 immunolocalization displays modest nuclear localization in embryos from the 2-cell, 4cell, 8-cell, morula, and blastocyst stages, though this was not quantified. Additionally, the KEAP1
immunofluorescence localization pattern consists of cytoplasmic fluorescent foci and a subcortical
cytoplasmic halo in each blastomere. By the blastocyst stage, KEAP1 immunofluorescence was
stronger in the outer TE cells than that observed for ICM cells; this difference was not quantified,
but was consistently observed across blastomere samples (Figure 10B).
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Figure 10. KEAP1 protein localization and mean percentage of KEAP1 positive cells at each major
stage of preimplantation embryo development.
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Figure 10. (A) Mean positive KEAP1 cells (%±SEM) at each stage of preimplantation
embryo development. Cytosolic KEAP1 was consistently present throughout all stages of
preimplantation embryo development, decreasing at the blastocyst stage (N=31). Percentage of
KEAP1 positive cells was significantly lower at the blastocyst stage (91.60±1.00%) compared with
the 2-cell stage (97.85±1.50%). Data were analyzed using one-way ANOVA with Tukey’s posthoc test to determine significance (*p<0.05). (B) Immunofluorescence images show KEAP1, Factin and DAPI localization at each major stage of preimplantation embryo development.
Cytosolic KEAP1 presence is evident at the 1-cell, 2-cell, 4-cell, 8-cell, morula and blastocyst
stages.
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3.3 Relative mRNA abundance of NRF2, KEAP1 & downstream
antioxidants during mouse preimplantation embryo development
Next, I characterized the relative mRNA abundance patterns for Nrf2, Keap1, and their
downstream targets Gpx1, Catalase and Sod1 during in vitro preimplantation embryo
development. The relative abundance of Nrf2 mRNA was significantly higher in blastocysts (5.52fold) compared with all other embryo stages (p<0.05; Figure 11A). Nrf2 mRNA abundance did
not differ significantly between 1-cell, 2-cell, 4-cell, 8-cell and morula embryos.
Similarly, the relative mRNA abundance of Keap1 was significantly higher in blastocysts (9.55fold) compared with all other cell stages (p<0.05; Figure 11B). Keap1 mRNA abundance did not
differ significantly between 1-cell, 2-cell, 4-cell, 8-cell, and morula embryos.
The relative mRNA abundance of Gpx1 displayed the highest transcript levels in blastocyst
embryos (58.39-fold) compared with 1-cell (p<0.01), 2-cell (p<0.05) and 4-cell embryos (p<0.05;
Figure 11C). Gpx1 transcript abundance did not significantly differ between the 1-cell, 2-cell, 4cell, 8-cell and morula groups, but showed a continuous increase in transcript abundance at each
stage of preimplantation development.
The relative mRNA abundance of Catalase was significantly higher in blastocysts compared with
all other developmental stages (p<0.0001), and showed a pronounced increase from the morula to
blastocyst stage (177.0-fold; Figure 11D). Catalase transcript abundance did not differ
significantly between the 1-cell, 2-cell, 4-cell, 8-cell and morula groups.
The relative mRNA abundance of Sod1 was highest in the blastocyst group (12.82-fold). Sod1
transcript abundance was significantly higher in blastocysts compared with 1-cell, 4-cell and 8cell embryos (p<0.05; Figure 11E). Sod1 mRNA abundance did not differ significantly between
the 1-cell, 2-cell, 4-cell, 8-cell and morula groups.
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Figure 11. Relative mRNA abundance of Nrf2, Keap1, Gpx1, Catalase and Sod1 during
mouse preimplantation embryo development.

46

Figure 11. Mean relative mRNA abundance (±SEM) of (A) Nrf2, (B) Keap1, (C) Gpx1, (D)
Catalase and (E) Sod1 at each stage of preimplantation embryo development, normalized to
Luciferase mRNA. Relative transcript abundances of Nrf2, Keap1, Gpx1, Catalase and Sod1
increase throughout mouse preimplantation embryo development. After embryo culture (N=3),
RNA was extracted from each group (PicoPure), reverse transcribed to cDNA (Sensiscript), and
cDNA quality was assessed. Real-time qPCR was performed using Taqman primers for Nrf2,
Keap1, Gpx1, Catalase and Sod1, and relative mRNA abundance was normalized to exogenous
Luciferase mRNA, then determined using the ∆∆Ct method with 1-cell as the baseline. (A)
Relative Nrf2 abundance was significantly higher in blastocysts compared with all other groups.
(B) Relative Keap1 abundance was significantly higher in blastocysts compared with all other
groups. (C) Relative Gpx1 abundance was significantly higher in blastocysts compared with 1cell, 2-cell and 4-cell groups. (D) Relative Catalase abundance was significantly higher in
blastocysts compared with all other groups. (E) Relative Sod1 abundance was significantly higher
in blastocysts compared with 1-cell, 4-cell and 8-cell groups. Relative transcript abundance in each
group was compared using one-way ANOVA with Tukey’s post-hoc test to determine significance
(*p<0.05, **p<0.01, ****p<0.0001).
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3.4 Effects of PA and OA treatment on NRF2 & KEAP1 protein
localization during mouse preimplantation embryo development
After characterizing Nrf2/Keap1 protein localization patterns and transcript levels during mouse
preimplantation development, I proceeded with determining how PA and OA treatment would
affect NRF2/KEAP1 protein and mRNA transcripts during preimplantation development. Twocell stage mouse embryos were cultured in KSOMaa supplemented with BSA, 100µM PA, 100µM
OA, or 100µM PA + 100µM OA under 37°C, 5% O2, 5% CO2 and 90% N2 conditions for periods
of 18, 24 and 48 hours.
Embryos from each treatment group were first processed for immunofluorescence localization
with either NRF2 or KEAP1 1° antibody, followed by DAPI and Rhodamine Phalloidin, and
imaged using confocal microscopy. Counts were performed for NRF2 positive nuclei and KEAP1
positive cells (Figures 12–14).

3.4.1 NRF2 & KEAP1 Localization after 18-hour Culture
NRF2 and KEAP1 protein immunolocalization were assessed after 18 hours of culture in the
presence of BSA, 100µM PA, 100µM OA, or 100µM PA+OA. The majority of treated embryos,
including those exposed to 100µM PA, proceeded to the 4-cell or 8-cell stage following 18 hours
of treatment. The effects of PA treatment on developmental stage were not apparent at this timepoint, but PA-treated embryos began to show binucleate cells, which are characteristic of this
treatment (Figure 12B).
After 18 hours of culture, nuclear NRF2 immunolocalization was present in embryos from all four
treatment groups. The mean percentage of NRF2 positive nuclei was significantly lower in PAtreated embryos (58.07±4.19%) compared with PA+OA treated embryos (73.16±3.56%; p<0.05).
The proportion of NRF2 positive nuclei did not differ significantly between any of the other
treatment groups (Figure 12A & B).
NRF2 immunofluorescence localization was consistently detected in the cytoplasm of blastomeres
in all treatments, though this pattern was not quantified. Within the cytoplasmic compartment,
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NRF2 immunofluorescence displayed a subcortical halo in each blastomere. Additionally, NRF2
immunostaining was absent from the nucleolus compartment in blastomeres from BSA (control),
PA, OA and PA+OA combination treated embryos (Figure 12B).
Cytosolic KEAP1 localization was present in all treatment groups at the 18 hour time-point.
However, the proportion of KEAP1 positive cells did not differ significantly between any of the
four treatments. Notably, the frequency of KEAP1 positive cells was above 90% in each group.
KEAP1 frequencies were 97.18±0.95% for OA-treated embryos, 99.12±0.51% for BSA,
99.09±0.66% for PA, and 97.75±0.98% for PA+OA treated embryos (Figure 12C & D). KEAP1
immunofluorescence localization also displayed modest nuclear immunolocalization, and a
subcortical halo distribution in the cytoplasm of blastomeres from all four treatments.
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Figure 12. Effects of 18 hour PA and OA treatment on NRF2 and KEAP1 protein localization.
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Figure 12. (A) Mean positive NRF2 nuclei (%±SEM) in embryos following 18-hour culture
in BSA, PA, OA or PA+OA treatment conditions. Treatment with 100 µM PA significantly
decreased the percentage of NRF2 positive nuclei per embryo. Mouse two-cell stage embryos were
cultured in vitro in KSOMaa media containing BSA, 100 µM PA, 100 µM OA, or 100 µM PA+OA
for 18 hours under 37°C, 5% O2, 5% CO2 and 90% N2 conditions (N=36). PA-treated embryos
displayed a lower mean percentage of NRF2 positive nuclei (58.07±4.19%) compared with the
PA+OA group (73.16±3.56%). Data were analyzed using one-way ANOVA with Tukey’s posthoc test (*p<0.05). (B) Immunofluorescence images show NRF2, F-actin and DAPI
localization following 18-hour culture in BSA, PA, OA or PA+OA treatment conditions.
Nuclear NRF2 localization is evident in all treatment groups at 18 hours of culture. (C) Mean
positive KEAP1 cells (%±SEM) in embryos following 18-hour culture in BSA, PA, OA or
PA+OA treatment conditions. Inclusion of FFA in embryo culture media did not impact KEAP1
positive cells per embryo (N=34). The mean percentage of KEAP1 positive cells in the BSA
control (99.12±0.51%), PA (99.09±0.66%), OA (97.18±0.95%) and PA+OA (97.75±0.98%)
groups did not differ significantly. Data were analyzed using one-way ANOVA with Tukey’s posthoc test. (D) Immunofluorescence images showing KEAP1, F-actin and DAPI localization
following 18-hour culture in BSA, PA, OA or PA+OA treatment conditions. Cytosolic KEAP1
localization is evident in all treatment groups at 18 hours of culture.
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3.4.3 NRF2 & KEAP1 Localization after 24-hour Culture
After 24 hours of culture and treatment with BSA (control), 100 µM PA, 100 µM OA, or 100 µM
PA+OA, nuclear NRF2 immunolocalization was present in embryos from all treatment groups.
The inclusion of FFA in embryo culture media did not have a significant impact on the mean
percentage of NRF2 positive nuclei per embryo in any of the treatment groups (Figure 13A and
13B). Like the 18 hour time-point, NRF2 immunolocalization was consistently detected in the
cytoplasm, and was absent from the nucleoli of blastomeres from all treatment groups.
Likewise, cytoplasmic KEAP1 localization was observed in all treatment groups at the 24 hour
time-point. The mean percentage of KEAP1 positive cells did not differ significantly between any
of the four treatments. Similar to the 18 hour time-point, the frequency of KEAP1 positive cells
was high (>90%) in all treatment groups (Figure 13C and 13D).
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Figure 13. (A) Mean positive NRF2 nuclei (%±SEM) in embryos following 24-hour culture
in BSA, PA, OA or PAOA treatment conditions. Inclusion of FFA in embryo culture media did
not significantly impact the mean percentage of NRF2 positive nuclei per embryo (N=40). The
mean percentage of NRF2 positive nuclei in the BSA (66.48±4.24%), PA (73.93±3.70%), OA
(74.03±3.45%) and PA+OA (73.14±3.11%) groups were not significantly different. (B)
Immunofluorescence images showing NRF2, F-actin and DAPI localization following 24hour culture in BSA, PA, OA or PAOA treatment conditions. Nuclear NRF2 localization is
evident in all treatment groups at 24 hours of culture. (C) Mean positive KEAP1 cells (%±SEM)
in embryos following 24-hour culture in BSA, PA, OA or PAOA treatment conditions.
Inclusion of FFA in embryo culture media did not significantly impact the mean percentage of
KEAP1 positive cells per embryo (N=39). The mean percentage of KEAP1 positive cells in the
BSA (98.21±0.81%), PA (97.89±0.83%), OA (98.51±0.66%) and PA+OA (98.65±0.69%) groups
did not differ significantly from one another. (D) Immunofluorescence images showing KEAP1,
F-actin and DAPI localization following 24-hour culture in BSA, PA, OA or PAOA treatment
conditions. Cytosolic KEAP1 localization is evident in all treatment groups at 24 hours of culture.
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3.4.4 NRF2 & KEAP1 Localization after 48-hour Culture
After 48 hours of treatment with BSA (control), 100 µM PA, 100 µM OA, or 100 µM PA+OA,
nuclear NRF2 localization was present in embryos from all four treatment groups. Inclusion of
100µM PA in embryo culture media significantly decreased the mean percentage of NRF2 positive
nuclei (73.62±2.34%) compared with BSA control (90.07±1.15%), OA (87.65±1.60%), and
PA+OA (90.50±1.40%) treatment groups (p<0.0001; Figure 14A and 14B). The frequency of
NRF2 positive nuclei did not differ significantly between BSA, OA and PA+OA treated embryos.
Nuclear NRF2 immunolocalization was brighter in the TE cells than the ICM in BSA, OA and
PA+OA treatment groups, though this was not quantified. NRF2 immunolocalization was also
consistently detected in the cytoplasm, though the NRF2 labelling was more intense in the nuclei
when present.
KEAP1 displayed a consistent cytosolic immunolocalization pattern in embryos from all four
treatment groups following 48-hour culture. Inclusion of 100 µM OA in embryo culture media
significantly decreased the percentage of KEAP1 positive cells per embryo (53.31±2.79%)
compared with the BSA control (71.97±2.41%), PA (76.95±2.09%) and PA+OA (86.38±1.50%)
treatment groups (p<0.0001). The frequency of KEAP1 positive cells was highest in PA+OA
treated embryos, which was significantly higher than the BSA control (p<0.0001) and PA (p<0.05)
groups (Figure 14C and 14D).
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Figure 14. (A) Mean positive NRF2 nuclei (%±SEM) in embryos following 48-hour culture
in BSA, PA, OA or PAOA treatment conditions. Inclusion of 100 µM PA in embryo culture
media significantly decreased the percentage of positive NRF2 nuclei per embryo (N=37). PAtreated embryos displayed a lower percentage of positive NRF2 nuclei (73.62±2.35%) compared
with BSA control (90.07±1.15%), OA (87.65±1.60%), and PA+OA (90.50±1.41%) treatments.
Data were analyzed using one-way ANOVA with Tukey’s post-hoc test (****p<0.0001). (B)
Immunofluorescence images showing NRF2, F-actin and DAPI localization following 48hour culture in BSA, PA, OA or PAOA treatment conditions. Nuclear NRF2 localization is
evident in all treatment groups. (C) Mean positive KEAP1 cells (%±SEM) in embryos following
48-hour culture in BSA, PA, OA or PAOA treatment conditions. Inclusion of 100 µM OA in
embryo culture media significantly decreased the percentage of KEAP1 positive cells per embryo
(N=91). OA-treated embryos showed a significantly lower percentage of KEAP1 positive cells
(53.31±2.79%) compared with the BSA (71.97±2.41%), PA (76.95±2.09%), and PA+OA
(86.38±1.50%) treatment groups. Additionally, PA+OA treatment showed the highest percentage
of KEAP1 positive cells compared with the BSA and PA treatments. Data were analyzed using
one-way ANOVA with Tukey’s post-hoc test (*p<0.05, ****p<0.0001). (D)
Immunofluorescence images showing KEAP1, F-actin and DAPI localization following 48hour culture in BSA, PA, OA or PAOA treatment conditions. Cytosolic KEAP1 localization
is evident in all treatment groups at 48 hours of culture.

57

3.5 Effects of PA and OA treatment on relative mRNA abundance
of NRF2, KEAP1 & downstream antioxidants during
preimplantation development
3.5.1 Relative mRNA Abundance after 24-hour Culture
Next, I characterized the effects of BSA (control), 100 µM PA, 100 µM OA, or 100 µM PA+OA
combined treatment on Nrf2, Keap1, Gpx1, Catalase and Sod1 mRNA relative transcript levels
following 24 hours of culture. The relative transcript abundances of Nrf2, Keap1, Gpx1, Catalase
and Sod1 were not significantly impacted by 24 hour FFA treatments.
Relative Nrf2 transcript abundance did not differ significantly between any groups (Figure 16A).
The relative mRNA abundance of Keap1 transcripts also displayed no significant differences
between the BSA, PA, OA and PA+OA groups (Figure 16B). Like Keap1, the relative Gpx1
transcript abundance showed no significant differences between any of the four treatments (Figure
16C). The relative transcript abundances of Catalase also did not differ significantly between
treatment groups (Figure 16D). Likewise, the relative mRNA abundance of Sod1 was not
significantly different between treatment groups (Figure 16E).
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Figure 15. Effects of 24 hour PA and OA treatment on relative mRNA abundance of NRF2,
KEAP1, Gpx1, Catalase and Sod1.
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Figure 16. Mean relative mRNA abundance (±SEM) of Nrf2, Keap1, Gpx1, Catalase, and
Sod1 following 24-hour culture in BSA, PA, OA or PA+OA treatment conditions. Relative
transcript abundance did not differ significantly after 24 hours of treatment with FFAs for (A)
Nrf2, (B) Keap1, (C) Gpx1, (D) Catalase or (E) Sod1 (N=3). Data were analyzed using one-way
ANOVA with Tukey’s post-hoc test.
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3.5.1 Relative mRNA Abundance after 48-hour Culture
After characterizing the impact of 24-hour FFA treatments on Nrf2, Keap1, Gpx1, Catalase and
Sod1 transcript abundance, I next characterized their relative mRNA transcript abundances after
48 hours of treatment with BSA (control), 100 µM PA, 100 µM OA, or 100 µM PA+OA.
Inclusion of FFA in embryo culture media for 48 hours did not significantly impact the relative
mRNA abundance of Nrf2, Keap1, Gpx1, Catalase and Sod1. Relative mRNA abundance of Nrf2
did not differ significantly between BSA, PA, OA or PA+OA treatment groups (Figure 15A).
Relative Keap1 transcript also showed no significant differences between groups (Figure 15B).
Similarly, relative mRNA abundance of Gpx1 did not differ between treatments (Figure 15C).
Relative Catalase mRNA abundance also did not differ significantly between any of the four
treatments (Figure 15D). Finally, relative transcript abundance of Sod1 also had no significant
differences observed across treatments (Figure 15E).
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Figure 16. Effects of 48 hour PA and OA treatment on relative mRNA abundance of Nrf2,
Keap1, Gpx1, Catalase and Sod1.
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Figure 15. Mean relative mRNA abundance (±SEM) of Nrf2, Keap1, Gpx1, Catalase, and
Sod1 following 48-hour culture in BSA, PA, OA or PA+OA treatment conditions. Relative
transcript abundance did not differ significantly after 48 hours of treatment with FFAs for (A)
Nrf2, (B) Keap1, (C) Gpx1, (D) Catalase or (E) Sod1 (N=4). Data were analyzed using one-way
ANOVA with Tukey’s post-hoc test.
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Chapter 4: Discussion
As two of the most physiologically relevant and abundant FFAs in the human body, PA and OA
have been studied extensively in many tissues. Research has revealed that PA and OA have
differential effects on cells, tissues, organs and whole-body physiology including the
cardiovascular system, adipocytes, lung tissue, hepatocytes and osteoblast-like cells (Chu et al.,
2019; Hao et al., 2020; Meng et al., 2019; Ricchi et al., 2009; L. Yang et al., 2018). Saturated fatty
acids, and especially PA, are associated with detrimental effects in most tissues, while OA displays
favourable physiological outcomes that generally oppose the effects of PA (Chu et al., 2019; Hao
et al., 2020; Meng et al., 2019; Ricchi et al., 2009; L. Yang et al., 2018). The intracellular
mechanism of PA handling involves production of DAG and its conversion to ceramide, which is
associated with deleterious outcomes; oleic acid, however, is mainly incorporated into TAG,
protecting cells from inflammation and negative outcomes (Palomer et al., 2018).
Not surprisingly, PA and OA also have differential effects on the reproductive tract (Aardema et
al., 2011; Colvin et al., 2017; Leroy et al., 2005). A previous study indicated that PA induces
toxicity in human syncytiotrophoblasts, characterized by induction of ER stress and apoptosis,
while treatment with OA is not toxic, and combined PA+OA abrogates the negative impact of PA
alone (Colvin et al., 2017). Another study investigated the effects of PA and OA treatment on
maturing bovine oocytes and discovered that while PA treatment decreases developmental
competence, OA treatment restores developmental competence, and thus has the capacity to
counteract deleterious effects of PA (Aardema et al., 2011).
Recent studies from my lab provided foundational knowledge about the differential effects of PA
and OA on mouse preimplantation embryo development, including blastocyst development, ROS
production, and ER stress pathway expression (Yousif et al., 2020). My thesis enhances our
knowledge of differential PA and OA treatment effects during mouse preimplantation
development by characterizing and implicating the NRF2/KEAP1 antioxidant response pathway,
and its downstream antioxidant gene targets, as components of the overall adaptive stress response
mechanism that preimplantation mammalian embryos employ in response to aberrant
environmental FFA concentrations.
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I first set out to validate the impact of PA and OA on mouse preimplantation embryo development
by defining the stage-specific developmental breakdown resulting from PA and OA treatment.
Secondly, I characterized the protein localization and relative mRNA transcript profiles for
NRF2/KEAP1 throughout normal mouse preimplantation development, in vitro, for the first time.
Thirdly, I characterized the effects of PA and OA treatment, alone and in combination, on the
protein localization and mRNA transcript levels of NRF2/KEAP1 during mouse preimplantation
development. Lastly, I investigated the consequences of PA and OA treatments on antioxidant—
Sod1, Gpx1, and Catalase—relative mRNA levels during mouse preimplantation development.
Overall, my thesis aimed to provide greater insight into the effects of elevated FFA exposure as a
model for eventually understanding the mechanisms underlying the well-characterized negative
effects of obesity on human fertility and conception. In addition, in vitro culture of mouse embryos
was employed with the goal of eventually translating my findings to improving conditions for in
vitro culture of human embryos, with the expectation that embryo viability and developmental
competence can be improved, especially for patients who are obese.
My primary hypothesis was that treatment of mouse preimplantation embryos with PA activates
the NRF2/KEAP1 antioxidant response pathway, and that pathway activation is alleviated by cotreatment with OA.

4.1 Mouse preimplantation embryo development following PA and
OA treatment
Our lab previously showed that exposure to 100 µM PA in embryo culture impaired mouse
preimplantation embryo development to the blastocyst stage, while co-treatment with 100 µM OA
rescued blastocyst development rates (Yousif et al., 2020). Consistent with these previous findings,
I observed that PA-treated embryos displayed a significant impairment in development. Less than
16% of 2-cell embryos treated with PA successfully reached the blastocyst stage. In addition,
morphological abnormalities such as binucleate cells were frequently observed in PA-treated
embryos, but not in BSA controls, OA alone, or PA+OA combination treatments. Embryos
exposed to OA alone or PA+OA co-treatment had similar blastocyst formation rates to the BSA
control, which were all above 60% of initial 2-cells placed in treatment. Our chosen treatment
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concentrations of 100 µM PA and OA are close to serum levels of healthy BMI individuals, but
lower than the range found in obese individuals, which is typically between 200–400 µM (X. Chen
et al., 2010; Colvin et al., 2017; Villa et al., 2009). Increased serum FFAs in obese individuals are
reflected in the follicular fluid levels, with follicular levels typically representing anywhere from
1/3 to 1/2 of serum concentrations (Valckx et al., 2014). Very few studies have attempted to
measure FFA levels within mammalian reproductive tracts, but Yousif et al. (2020) reported that,
on average, female CD-1 mice maintained a concentration of nearly 400 µM PA in the oviduct
and 168 µM PA in the uteri. In contrast, OA levels were only 33 µM in the oviduct and 51 µM in
the uteri (Yousif et al., 2020). Furthermore, Yousif et al. (2020) determined that while blastocyst
frequency was significantly decreased when deploying PA at concentrations as low as 50 µM, the
dose of 100 µM PA fell in the middle of the concentration response curve, where 250 µM PA
completely blocked blastocyst development. This provides the rationale for using 100 µM PA and
OA treatments in my study. Importantly, the PA and OA treatments used in my experiments were
conjugated to BSA with a 2:1 ratio, which is a physiological FFA to BSA ratio, and is consistent
with the state of non-esterified fatty acids found in follicular fluid (Valckx et al., 2014).
While my experimental conditions are in vitro, and thus cannot claim to replicate in vivo
reproductive tract conditions, my results definitively show that direct exposure to 100 µM PA has
a detrimental effect on preimplantation embryo development, while 100 µM OA does not impede
embryo development. Furthermore, OA rescues development when treated in combination with
PA at 1:1 concentration. Finally, my breakdown of embryo stages in each treatment demonstrates
that the majority of PA-treated embryos remain at the 4- to 8-cell stages, along with an unusually
high percentage of 2-cells, following 48 hours of PA treatment.

4.2 NRF2 & KEAP1 protein localization during mouse
preimplantation embryo development
NRF2/KEAP1 signalling has been researched extensively as one of the dominant stress response
pathways in eukaryotic cells (Huang et al., 2015; Tonelli et al., 2018), including implications in
cancer, arthritis, multiple sclerosis, type 2 diabetes, Alzheimer’s and Parkinson’s diseases, and
cardiovascular disease (David et al., 2017; de la Vega et al., 2018; Dodson et al., 2019; Osama et
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al., 2020; Petrillo et al., 2020; Reuland et al., 2013; Su et al., 2018). However, very few studies
have considered NRF2/KEAP1 function during mammalian preimplantation development (Amin
et al., 2014; Khadrawy et al., 2020; Kim et al., 2019; Qiao et al., 2021) and none to date have
characterized the subcellular localization of NRF2 and KEAP1 proteins and their relative transcript
levels during mouse preimplantation development.
NRF2 is a nuclear transcription factor that dissociates from KEAP1, its cytosolic binding partner,
and localizes to the nucleus under cellular stress conditions (Cullinan et al., 2004; Suzuki &
Yamamoto, 2015) to exert effects on the downstream pathway, including antioxidant genes Gpx1,
Catalase and Sod1 (Glorieux et al., 2015; Jerotic et al., 2019; Weydert & Cullen, 2010; Yan et al.,
2019; W. Yang et al., 2015). I consistently detected NRF2 localization in the nuclei of blastomeres
throughout all stages (1-cell, 2-cell, 4-cell, 8-cell, morula, and blastocyst) of preimplantation
embryo development. The percentage of nuclei displaying NRF2 localization increased throughout
development, peaking at the blastocyst stage. Given that NRF2 is a nuclear transcription factor,
localization in the nucleus is expected when the protein is active (Ma, 2013; Nguyen et al., 2005).
Previous studies have identified roles for both basal and stress-inducible activation of
cytoprotective genes by NRF2 (Tonelli et al., 2018). The presence of nuclear NRF2 throughout
preimplantation embryo development supports the existence of basal NRF2 activity in embryos in
the absence of acute stress conditions. Embryo culture, however, is a known stressor of early
embryos (Amin et al., 2014; Khadrawy et al., 2020; Kim et al., 2019) and thus the detection of
nuclear NRF2 in vitro does not guarantee that NRF2 would maintain similar nuclear localization
throughout preimplantation development in vivo. Recent studies by Kim et al. (2019) have shown
that melatonin treatment of preimplantation porcine embryos results in upregulated Nrf2, and Sod1
expression that was negated in the presence of brusatol, which is an NRF2 inhibitor. In addition,
Amin et al. (2014) demonstrated that embryo culture under atmospheric O2 influences NRF2 and
downstream antioxidant enzymes during bovine preimplantation development, as embryos
cultured under 20% O2 displayed elevated Nrf2 and antioxidant enzyme mRNA levels.
Furthermore, the addition of quercetin (a plant-derived flavonoid and antioxidant) to bovine
preimplantation embryo culture resulted in enhanced Nrf2 and downstream antioxidant enzyme
expression, along with increased bovine blastocyst formation under 20% O2 culture conditions
(Khadrawy et al., 2020). Thus, culture conditions alone can induce expression of Nrf2. However,
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my studies are the first to characterize NRF2/KEAP1 localization and transcript abundance during
mouse preimplantation development.
Interestingly, NRF2 immunolocalization was not detected in the nucleoli of preimplantation
blastomeres. The nucleolus is generally regarded as the centre for ribosomal RNA synthesis,
though recently more extensive functions have been recognized, including a potential role in
mRNA production and trafficking (Pederson, 2011). Boulon et al. (2010) describe the nucleolus
as a central hub for coordinating cellular stress responses; however, the two major players
mentioned are the kinase mammalian target of rapamycin (mTOR) and p53 pathways (Boulon et
al., 2010). Taken together with my NRF2 immunolocalization findings, this raises the possibility
that the NRF2/KEAP1 pathway is not directly involved in coordinating stress responses in the
nucleolus.
NRF2 immunofluorescence localization was also detected in the cytoplasm of blastomeres
throughout all stages of preimplantation embryo development. The inducible mechanism of NRF2
activation dictates that under basal conditions, NRF2 remains sequestered in the cytosol by KEAP1
for proteasomal degradation (Ma, 2013; Tonelli et al., 2018). Therefore, the inactive fraction of
NRF2 protein would be expected to localize in the cytosolic compartment, which is consistent with
my results.
KEAP1 immunofluorescence localization was consistently detected in the cytoplasm of
blastomeres throughout all stages of preimplantation embryo development. This localization
pattern was expected, since KEAP1 is the cytoplasmic binding partner and primary mediator of
NRF2 proteasomal degradation (Canning et al., 2015). The percentage of KEAP1 positive
blastomeres decreased throughout development to the blastocyst stage, which was the inverse
pattern observed in NRF2 nuclei, suggesting that increased NRF2 positive nuclei in blastocysts
may be mediated by a decrease in cytosolic KEAP1 protein, allowing more NRF2 protein to enter
the nuclear compartment.
Interestingly, KEAP1 immunolocalization showed some nuclear localization from the 2-cell stage
onward. This was initially unexpected, but studies have reported that KEAP1 engages in
nucleocytoplasmic shuttling to retrieve NRF2 from the nucleus and target it for degradation
(Nguyen et al., 2005, 2009). It is also likely that KEAP1 has additional nuclear binding partners
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(Karapetian et al., 2005). Additionally, the KEAP1 cytoplasmic immunolocalization pattern
consisted of small, fluorescent foci organized into a fluorescent halo lining the margins of each
blastomere. This cellular region houses the actin cytoskeleton, and studies show that KEAP1 is
associated with the actin cytoskeleton in many cell systems (Kang et al., 2004). KEAP1 is
described as a component of cell adhesion complexes including focal adhesions and adherens
junctions (Velichkova & Hasson, 2003; Wu et al., 2018). Characteristics of KEAP1 in adhesion
complexes included co-localization with filamentous actin and distinct KEAP1 foci, both of which
are consistent with my findings (Velichkova & Hasson, 2003; Wu et al., 2018). To my knowledge,
KEAP1 localization during mouse preimplantation embryo development has not been
characterized until now.

4.3 Relative mRNA abundance of Nrf2, Keap1 & downstream
antioxidants during mouse preimplantation embryo development
The relative transcript levels of Nrf2, Keap1, Gpx1, Catalase and Sod1 all increased significantly
during the mouse preimplantation period, peaking at the blastocyst stage. The mouse embryo
undergoes major genome activations and gene expression bursts during preimplantation
development. These include zygotic, mid-preimplantation and pre-blastocyst gene expression
bursts that allow the preimplantation embryo to shift away from oogenetic or maternal transcripts
and towards autonomous control of the embryonic genome for development (Hamatani et al.,
2004; Knowland & Graham, 1972; Lee et al., 2014). In addition to gene expression pattern shifts,
we would also expect to observe an increase in mRNA content throughout preimplantation
development due to an exponential increase in the number of blastomeres following each cell
division. Accordingly, all five of the mRNA markers that I characterized showed a significant
increase in relative transcript abundance between the 1-cell zygote and blastocyst stage of
development. However, Nrf2, while still displaying the same overall increase, had an interesting
difference in its relative mRNA abundance pattern compared with the other genes; the 1-cell
zygotes displayed a higher abundance of Nrf2 transcripts relative to 2-cell, 4-cell and 8-cell
embryos. This pattern is characteristic of maternal transcripts derived from the oocyte slowly
degrading during each cell division until the embryonic genome becomes transcriptionally active
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and begins producing its own transcripts to support further development (Hamatani et al., 2004;
Lee et al., 2014; Vastenhouw et al., 2019).
The relative abundances of Gpx1 and Catalase mRNA in blastocyst embryos were both
exceptionally high, with increases of approximately 60-fold and 177-fold, respectively.
Antioxidant enzymes are commonly found in cell systems, as they require the ability to be rapidly
mobilized in response to stressful conditions (Weydert & Cullen, 2010). Sod1 relative transcript
levels displayed a more modest increase in blastocysts of approximately 13-fold. However, it is
challenging to estimate the full significance of changes in mRNA levels between target genes, as
each target has unique dynamics such as mRNA half-lives, translational efficiencies, protein halflives, enzymatic activities and other regulatory mechanisms that combine to produce unique
relative transcript patterns during mouse preimplantation development (Proud, 2001; Roy &
Jacobson, 2013). Each antioxidant enzyme regulates a distinct process in controlling ROS levels,
such that Sod1 converts superoxide radicals into hydrogen peroxide and molecular oxygen, while
Gpx1 and Catalase are both responsible for catalyzing the conversion of hydrogen peroxide into
water (Weydert & Cullen, 2010).

4.4 Effects of PA and OA treatment on NRF2 & KEAP1 protein
localization during mouse preimplantation embryo development
PA and OA have documented differential effects in many tissues, including preimplantation
embryo development (Yousif, 2019), but little is known about their effects on the NRF2/KEAP1
signalling pathway during this developmental period. To investigate potential time-related effects
of PA and OA treatment on NRF2/KEAP1 localization and relative mRNA levels, I conducted
experiments employing 18, 24 and 48 hour treatment times.
After 18 hours of treatment, most initial 2-cell embryos—including PA-treated embryos—
developed to the 4-cell or 8-cell stage, which is the expected developmental range for embryonic
day 2–2.5 mouse embryos (Cockburn & Rossant, 2010). After 24 hours of PA and OA treatment
in in vitro embryo culture, the majority of embryos in all groups remained between the 4-cell and
8-cell stages, but displayed a greater proportion of 8-cells than the 18 hour time-point. No obvious
morphological effects of PA or OA treatment were apparent at these earlier time-points, but PA70

treated embryos began to show characteristic binucleate cells, determined by DAPI staining.
Development after 48 hours of PA treatment in vitro was, of course, severely reduced as expected
and as described in Section 4.1. BSA (control), OA, and PA+OA co-treated embryos readily
developed to the blastocyst stage by 48 hours.
NRF2 immunofluorescence localization was consistently detected in the nuclei of blastomeres
from all four treatment groups—BSA (control), 100 µM PA, 100 µM OA, and 100 µM PA+OA—
after 18, 24, and 48 hours of treatment in vitro. However, the percentage of NRF2 positive nuclei
was lowest in PA-treated embryos at the 18 and 48 hour time-points. This outcome was unexpected
and does not support my primary hypothesis. Research has indicated that PA treatment in many
cell systems is linked to induction of ER stress and often apoptosis, in part by the metabolism of
PA to DAG and its conversion to ceramide (Wali et al., 2006). The conversion of PA to ceramide
activates the NRF2/KEAP1 pathway, and increases translocation of NRF2 to the nucleus, which
occurs in many tissues as a primary stress response mechanism. Interestingly, Guo et al. (2020)
reported that PA treatment downregulates mRNA and protein expression of mitochondrial
biogenesis regulators and the antioxidant response, including NRF2 and PGC1𝛼 in C1C12 skeletal
muscle myoblasts. Furthermore, Guo et al. (2020) suggested that this effect of PA treatment on
reducing NRF2, antioxidant response and mitochondrial function can be alleviated by treatment
with human fibroblast growth factor-19 (FGF-19; mouse homologue, FGF-15) by activating the
AMP-activated protein kinase (AMPK)/PGC1𝛼 pathways in C2C12 skeletal muscle myoblasts.
Thus, this study indicates that PA treatment can be linked with a downregulation of Nrf2
expression in skeletal muscle (Guo et al., 2020), and provides a possible explanation for the
reduced percentage of nuclear NRF2 in PA-treated embryos that I observed after 18 and 48 hours
of culture.
It must also be stated, however, that while the proportion of NRF2 nuclei was reduced in 18 and
48 hour PA-treated embryos compared with other treatment groups, the overall NRF2
immunofluorescence intensity was not measured in this study. It is possible that total NRF2 nuclear
protein levels were not affected. It was not possible to collect a sufficient number of
preimplantation embryos for quantitative Western blot analysis, nor did we feel confident in
attempting to quantify differences in fluorescence intensity as a surrogate for Western blot protein
quantification. Further analysis is required to validate and quantify the changes in nuclear NRF2
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levels that arise in response to PA treatment. If the discoveries from my research are supported by
future studies, that would certainly suggest that the intracellular mechanism of PA action prevents
embryos from properly mobilizing the NRF2/KEAP1 pathway in response to stress. This in turn
could represent a major component of how PA treatment negatively impacts preimplantation
embryo development. The proportion of immunofluorescent NRF2 positive nuclei did not differ
significantly between BSA (control), OA, and PA+OA co-treated embryos after 18 or 48 hour
culture. This finding suggests two things: first, that OA treatment likely does not suppress NRF2
activation, and second, that co-treatment with PA+OA at equal concentrations rescues the impact
of PA alone on NRF2 nuclear localization.
Cytoplasmic NRF2 immunofluorescence localization was observed in all treatment groups
following 18, 24, and 48 hours of culture, but this signal was not quantified. As previously
discussed, inactive NRF2 remains bound to KEAP1 in the cytoplasmic compartment (Ma, 2013;
Tonelli et al., 2018). NRF2 was absent from nucleoli in all embryos regardless of treatment,
consistent with my observations from the NRF2 developmental series, suggesting that PA and OA
do not alter sub-nuclear NRF2 localization patterns. Finally, NRF2 immunolocalization was
detected around cell margins in the 18, 24 and 48 hour time-points, suggesting that inactive NRF2
protein associates with cell adhesion complexes via KEAP1 during preimplantation embryo
development (Velichkova & Hasson, 2003).
KEAP1 immunofluorescence localization was detected in the cytoplasm of blastomeres from BSA
(control), PA, OA, and PA+OA co-treated embryos at all time points. The percentage of KEAP1
positive cells was exceptionally high (>90%) in all treatment groups after 18 and 24 hour culture
and did not differ significantly between them. This finding is consistent with reported KEAP1
localization studies applied to many cell types and tissues (Canning et al., 2015; Suzuki &
Yamamoto, 2015). KEAP1 immunofluorescence included occasional nuclear localization, and as
mentioned, likely performs nucleocytoplasmic shuttling while regulating NRF2 localization within
the cell (Karapetian et al., 2004; Nguyen et al., 2005; Nguyen et al., 2009). Additionally, KEAP1
immunolocalization in embryos after 18, 24 and 48 hour culture displayed the same fluorescent
halo that was observed in the control developmental series, likely associated with cell adhesion
complexes and the actin cytoskeleton (Velichkova & Hasson, 2003; Wu et al., 2018).
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Unexpectedly, after 48 hours of in vitro embryo culture, the percentage of KEAP1 positive cells
was significantly lower in OA-treated embryos compared with BSA, PA, and PA+OA cotreatments. Given that inclusion of PA in culture media decreased the percentage of NRF2 positive
nuclei, and OA exerts protective effects to counteract PA treatment, I would propose that OA
treatment may downregulate KEAP1 protein, which should mobilize compensatory NRF2
activation. Overall, KEAP1 immunofluorescence displayed cytoplasmic localization at the 18, 24,
and 48 hour time points, in all treatments that were investigated, and this localization pattern was
consistent with my expectations and the current literature.
The NRF2 immunofluorescence localization outcomes at the 24 hour time-point were inconsistent
with the 18 and 48 hour time-points, since no significant differences in the percentage of NRF2
positive nuclei were observed between treatment groups. This suggests that nuclear NRF2
localization is affected by PA treatment time during preimplantation development, and perhaps
cell cycle dynamics (Y. Lin et al., 2018; Márton et al., 2018). Our time course for NRF2
immunofluorescence suggests a mechanism where NRF2 cycles into and out of the nucleus over
specific time periods. In addition, KEAP1 nuclear localization was most prevalent at 24 hours
compared with 18 and 48 hours, though this was not quantified in this study. The KEAP1
immunolocalization pattern after 24 hours of treatment supports a temporal mechanism for
shuttling the NRF2/KEAP1 proteins between cytoplasmic and nuclear regions. An increase in
nuclear KEAP1 presence could indicate increased nucleocytoplasmic shuttling activity
(Karapetian et al., 2005; Nguyen et al., 2005, 2009; Velichkova & Hasson, 2005) during the 4-cell
to 8-cell transition, which coincides with 24 hours of embryo culture. This may reflect increased
nuclear NRF2 shuttling during the 4-cell to 8-cell transition, independent of either PA or OA
treatment. NRF2 plays a role in regulating the cell cycle, with one study indicating that NRF2
inhibition prevents progression of mouse embryos past the 4-cell stage (Lin Y et al., 2018). Thus,
it is plausible that NRF2 activation (and nucleocytoplasmic KEAP1 shuttling) occurring in
preparation for cleavage divisions would override observable differences in NRF2/KEAP1
localization between BSA (control), PA, OA, and PA+OA co-treatments after 24 hours of in vitro
embryo culture. This possibility awaits further experimentation but represents one of the most
unique findings of my study.
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Overall, the immunofluorescence localization patterns of NRF2/KEAP1 did not support my
hypothesis, but there is certainly support for their occurrence within existing literature. It is
primarily interesting and novel that PA treatment does not increase the proportion of nuclear NRF2
localization during mouse preimplantation embryo development, but in fact decreases it. Previous
research in our lab showed that PA treatment increases ER stress pathway mRNAs; however, it
did not increase mitochondrial superoxide production (Yousif et al., 2020). Guo et al. (2020)
demonstrated that upregulating the antioxidant response was capable of attenuating PA effects,
and that PA reduces the mRNA and protein levels of NRF2. The duality of this response requires
more investigation, but it suggests that PA-induced stress and the NRF2 response battle one
another for dominance of cell function. In a study examining the effects of olive oil on murine
dermal fibroblasts, Romana-Souza et al. (2020) demonstrated an association between the OA
content of olive oil and increased Nrf2 expression. This finding is consistent with the high levels
of nuclear NRF2 seen after OA treatment in this thesis, which suggests that OA-induced NRF2
activity may in fact be a beneficial mechanism, providing protection during co-treatment with
PA+OA. Given the sensitivity and vulnerability of embryos during the preimplantation period,
especially during in vitro culture, it is possible that PA treatment at the levels investigated herein
simply overwhelmed adaptive mechanisms of the developing NRF2/KEAP1 pathway, resulting in
the severe developmental impairments observed following PA treatment.

4.5 Effects of PA and OA treatment on relative mRNA abundance
of Nrf2, Keap1 & downstream antioxidants during preimplantation
development
The purpose of investigating PA and OA treatment effects on Nrf2, Keap1, Gpx1, Catalase and
Sod1 relative mRNA levels was to determine whether FFA treatment exerted any control or
influence on target mRNA levels during mouse preimplantation development. The inclusion of
antioxidant targets—Gpx1, Catalase, and Sod1—was important to determine whether FFA effects
on NRF2/KEAP1 signalling correlated with variations in antioxidant mRNA levels.
I first characterized the effects of PA, OA, and co-treatment with PA+OA on relative mRNA
expression following the full 48 hour in vitro culture period. Interestingly, inclusion of FFA in
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culture media did not significantly impact the relative mRNA expression of any of the five genes
between treatment groups, though variability between replicates was reasonably high. The relative
mRNA abundance of Nrf2 was lower in PA-treated embryos compared with OA-treated embryos,
much like the response observed in dermal fibroblasts when treated with olive oil (Romana-Souza
et al., 2020). Increased mRNA expression of Nrf2 after OA treatment represents a protective
measure that upregulates antioxidants, which OA induces in other cell types (Sargsyan et al.,
2016). PA treatment and PA+OA co-treatment did not significantly affect relative Nrf2 mRNA
expression compared to control levels. FFA treatment effects on Keap1 mRNA also did not result
in any significant differences, though there was one interesting trend, in that PA treatment
consistently produced the lowest relative Keap1 abundance across all experimental replicates.
In my assessment of protein localization patterns, the percentage of KEAP1 positive cells was
lowest in OA-treated embryos and was relatively high in PA-treated embryos. However, if PA
treatment inhibits the NRF2/KEAP1 pathway, this could reduce KEAP1 turnover and therefore
reduce mRNA production. Alternatively, NRF2/KEAP1 activation by OA treatment would rely
on higher transcript production of both Nrf2 and Keap1 to meet cellular demands.
The relative mRNA abundances of Gpx1, Catalase, and Sod1 did not show a direct association
with the mRNA patterns of Nrf2 and Keap1 between treatment groups. The relative mRNA
abundance of Gpx1 was lowest in PA-treated embryos, like Keap1; however, Gpx1 abundance in
OA-treated embryos was higher than after PA+OA co-treatment, matching Nrf2 trends in those
groups. The relative transcript abundance of Catalase was not significantly impacted by PA, OA,
or PA+OA treatments. Similarly, the relative transcript abundance of Sod1 was also not impacted
by PA or OA alone. However, relative Sod1 mRNA was highest in the PA+OA co-treatment
group. One important factor is the difference in average cell number between the BSA, PA, OA
and PA+OA treatment condition after 48 hours of culture. As discussed in Section 4.1, the majority
of BSA, OA and PA+OA embryos successfully develop to the blastocyst stage. In contrast, very
few PA-treated embryos achieve blastocyst development, and many of them arrest between the 4cell and 8-cell stages. My analysis of the developmental series gene expression in Section 4.3
demonstrated that the relative mRNA abundance of Nrf2, Keap1, Gpx1, Catalase and Sod1
increases greatly between the 1-cell and blastocyst stage embryos. Therefore, the fact that many
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PA-treated embryos arrested at earlier cell stages must be considered, as they are likely to have
lower relative mRNA content as a result of having fewer cells.
To address the confounding aspect of having different embryo stages and thus cell numbers
between treatment groups, I next characterized the relative mRNA transcript abundances of Nrf2,
Keap1, Gpx1, Catalase and Sod1 after only 24 hours of culture, since the majority of embryos in
all treatments achieve the 8-cell stage after this time-point. No significant differences were
observed between treatment conditions for any of the five genes, and thus no definitive conclusion
can be made from this analysis.
It is possible that FFA treatment effects do not extend to the mRNA level for Nrf2 and Keap1, but
the absence of a significant effect on all three antioxidant target mRNAs suggests that intra-assay
variability between experimental replicates was too high to allow differences, if they exist, to be
detected. The likely primary source of variability was inconsistent sample processing for RT-qPCR
analysis, since RNA extraction, reverse transcription and PCR amplification occurred on separate
days for all three replicates. There could have been some variation in embryo stage between
replicates, but the same stock FFA samples were used for all treatments and replicates, as were
consistent treatment times of 24 and 48 hours. Thus, the impact of PA and OA on Nrf2/Keap1
mRNAs and induction of Gpx1, Catalase and Sod1 expression remains inconclusive and will await
further experimentation to provide definitive outcomes regarding their relationships and effects on
their relative abundance across treatments.

4.6 Limitations and Future Directions
The research presented in this thesis is important because it dives further into the differential
effects that PA and OA have on mouse preimplantation embryo development by examining the
NRF2/KEAP1 pathway, the dominant antioxidant response pathway in eukaryotes, for the first
time. However, as with any study, there are naturally more experiments and techniques that could
have been employed to round out the results. All of my studies were completed during the Covid19 pandemic, but future research endeavors will address limitations that these circumstances
imposed on my thesis.
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Throughout this thesis, the main techniques that I employed to investigate protein localization and
gene expression were immunofluorescence imaging and quantitative real-time PCR, respectively.
Each of these techniques provides valuable information about the behaviour of the NRF2/KEAP1
pathway. Immunofluorescence localization beautifully visualizes the spatial localization of each
protein within each blastomere, and the entire embryo. However, the visual nature of confocal
images provides qualitative rather than quantitative information regarding protein distribution. In
this study, I took advantage of the expected localizations of NRF2 and KEAP1 to extract
quantitative assessments—NRF2 positive nuclei and KEAP1 positive cells—from these images.
However, my analysis does not attempt to quantify immunofluorescence intensity, or the degree
of co-localization between channels. Future studies should assess the intensity of overlap between
channels, for example, between the NRF2 and DAPI channels, in locations of interest to quantify
the extent of protein co-localization in those regions.
Similarly, quantitative real-time PCR provides us with valuable information about the relative
transcript levels of a given gene in relation to other groups being tested; however, Nrf2 and Keap1
are both important proteins that are tightly regulated at multiple levels. Thus, while it is important
to know about mRNA levels, they may not reflect the abundance, availability or function of the
actual protein. In the future, studies should focus on determining protein abundance (i.e. Western
Blots) or functional assays (i.e. phosphorylation) and its effects on protein activity.
Finally, all of my studies were applied to cultured embryos and thus are in vitro in nature. This
approach is important, of course, as full preimplantation culture to the blastocyst stage has emerged
as a critical technology for allowing the application of eSET in human fertility treatment clinics.
However, it cannot be denied that cultured mammalian embryos display significant differences
from in vivo-derived embryos. Thus, at some point it will be important to investigate expression
and localization of NRF2/KEAP1 proteins and mRNAs using in vivo mouse preimplantation
embryos.
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4.7 Conclusions and Significance
PA and OA have differential effects on many tissues, including mouse preimplantation embryos.
PA has proven to impair preimplantation embryo development and increase ER stress pathway
mRNAs, while OA rescues these effects. We confirmed that PA treatment impairs mouse
preimplantation embryo development. This thesis characterized the NRF2/KEAP1 antioxidant
response pathway throughout normal in vitro mouse preimplantation embryo development, and
investigated the effects of PA and OA treatments on NRF2/KEAP1 protein localization and
relative gene expression. My findings are summarized in Figure 17.
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Figure 17. Summary figure of thesis findings.
(A) Characterizing NRF2 and KEAP1 protein localization throughout in vitro mouse
preimplantation embryo development. (B) Characterizing the relative mRNA abundance of Nrf2,
Keap1, Gpx1, Catalase and Sod1 throughout preimplantation embryo development. (C) Effects of
PA and OA on mouse preimplantation development and the NRF2/KEAP1 pathway.
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Appendix B: Copyright Permissions for Figures
Figures 1 & 4, adapted from (Yousif, 2019):
Permission from Maisoon D. Yousif to use the aforementioned figures in the current thesis.

Figure 5, adapted from (Canning et al., 2015):
Link to copyright license: https://creativecommons.org/licenses/by/4.0/
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Figure 6, adapted from (Hiebert & Werner, 2019):
Including MDPI open access policy (right).

Figure 7, adapted from (Wang et al., 2017):
Highlighted portion of abstract indicates distribution of this article under the Creative Commons
Attribution License.
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(Oral presentation).

May 2021

Dionne G, Calder M, Betts D, Rafea BA, Watson AJ. Fatty acid regulation
of NRF2/KEAP1 pathway during mouse preimplantation embryo
development. London Health Research Day, Virtual Meeting (Poster
presentation).

May 2021

Dionne G, Watson AJ. Fatty acid regulation of NRF2/KEAP1 pathway
during mouse preimplantation embryo development. Developmental
Origins of Health and Disease, Virtual Meeting (Oral presentation).

June 2021

Dionne G, Calder M, Betts D, Rafea BA, Watson AJ. Fatty acid regulation
of NRF2/KEAP1 pathway during mouse preimplantation embryo
development. European Society of Human Reproduction and Embryology,
Virtual Meeting (Poster presentation).
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